Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to develop persisters to antibiotics by Morgan, Jasmine et al.
Microbiology
 
Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to




Full Title: Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to
develop persisters to antibiotics
Article Type: Research Article
Section/Category: Physiology and metabolism
Corresponding Author: J. ENRIQUE SALCEDO-SORA, M.D., Ph.D.
Liverpool Hope University
Liverpool, Merseyside UNITED KINGDOM
First Author: Jasmine Morgan, BSc
Order of Authors: Jasmine Morgan, BSc
Matthew Smith
Mark T Mc Auley, PhD
J. ENRIQUE SALCEDO-SORA, M.D., Ph.D.
Abstract: Bacteria can survive high doses of antibiotics through stochastic phenotypic
diversification. We present initial evidence that folate metabolism could be involved
with the formation of persisters. The aberrant expression of the folate enzyme gene fau
seems to reduce the incidence of persisters to antibiotics. Folate impaired bacteria had
a lower generation rate for persisters to both antibiotics ampicillin and ofloxacin.
Persister bacteria were detectable from the outset of the exponential growth phase in
the complex media. Gene expression analyses showed tentatively distinctive profiles in
exponential growth at times when bacteria persisters were observed.  Levels of
persisters were assessed  in bacteria with altered, genetically and pharmacologically,
folate metabolism. This work shows that by disrupting folate biosynthesis and usage,
bacterial tolerance to antibiotics seems to be diminished. Based on these findings
there is a possibility that bacteriostatic antibiotics such as antifolates could have a role
to play  in clinical settings where the incidence of antibiotic persisters seem to drive
recalcitrant infections.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
1 of 17 
Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to 1 




Jasmine Morgan, Morgajas@edgehill.ac.uk, Department of Biology, Edge Hill University,  St. 6 
Helens Road, Ormskirk, Lancashire, L39 4QP, UK 7 
 8 
Matthew Smith, smithm2@hope.ac.uk, School of Health Sciences, Liverpool Hope University, 9 
Hope Park, L16 9JD, Liverpool, UK 10 
 11 
Mark T. Mc Auley, m.mcauley@chester.ac.uk, Chemical Engineering Department, University 12 
of Chester, Thronton Science Park, CH2 4NU, Chester, UK 13 
 14 
J. Enrique Salcedo-Sora (Corresponding Author), salcede@hope.ac.uk, School of Health 15 
Sciences, Liverpool Hope University, Hope Park, L16 9JD, Liverpool, UK. Tel: (+44) 0151 16 
2912184 17 
 18 




Subject category:  Physiology and metabolism 23 
 24 
Word count: 4709 25 
 26 
Abbreviations: OCFM, folate one-carbon metabolism; 5-FCL, 5-formyltetrahydrofolate cyclo-27 
ligase;  TMP, trimethoprim; SMX, sulfamethoxazole; DMSO, dimethylsulfoxide; MIQE, 28 
Minimum information for publication of quantitative real-time PCR experiments; GCV, glycine 29 
cleavage complex;  30 
 31 
Manuscript Including References (Word document) Click here to download Manuscript Including References
(Word document) salcedo-
2 of 17 
Abstract 32 
Bacteria can survive high doses of antibiotics through stochastic phenotypic diversification. We 33 
present initial evidence that folate metabolism could be involved with the formation of 34 
persisters. The aberrant expression of the folate enzyme gene fau seems to reduce the incidence 35 
of persisters to antibiotics. Folate impaired bacteria had a lower generation rate for persisters to 36 
both antibiotics ampicillin and ofloxacin. Persister bacteria were detectable from the outset of 37 
the exponential growth phase in the complex media. Gene expression analyses showed 38 
tentatively distinctive profiles in exponential growth at times when bacteria persisters were 39 
observed.  Levels of persisters were assessed  in bacteria with altered, genetically and 40 
pharmacologically,  folate metabolism. This work shows that by disrupting folate biosynthesis 41 
and usage, bacterial tolerance to antibiotics seems to be diminished. Based on these findings 42 
there is a possibility that bacteriostatic antibiotics such as antifolates could have a role to play  43 




The capacity of microorganisms to survive or persist to antibiotics in a nonspecific manner, 48 
which is driven by phenotypic diversification rather than by genetic mutagenicity, has been 49 
shown to be of relevance in clinical settings [1, 2, 3, 4, 5]. Over the years evidence has 50 
gradually accumulated which suggests folates are involved in cellular growth regulation. For 51 
instance, folinic acid has been observed at high levels (≥70%) in 52 
dormant cellular forms, such as plant seeds and fungi spores [6, 7].  53 
Moreover, the overexpression of 5-formyltetrahydrofolate cyclo-ligase (5-FCL), the enzyme 54 
that recycles folinic acid has been associated with bacterial dormant phenotypes [8, 9]. 55 
Intriguingly, inhibiting 5-FCL in eukaryotes affects cell growth [10, 11], and 5-FCL has been 56 
described as a pathogenic factor necessary for drug tolerance in Mycobacterium [12]. 57 
 58 
Folate metabolism can be nominally divided into three parts: de novo biosynthesis, the folate 59 
cycle (equated here to one-carbon folate metabolism or OCFM), and the intake of folate 60 
intermediates via facilitated membrane transport [13]. Folate products are involved in anabolic 61 
metabolism which is directly coupled with cellular replication activities, such as DNA 62 
biosynthesis, and is also associated with the production of methionine and NADPH [6, 13, 14]. 63 
The potential roles of folate metabolism in antibiotic persisters have significant pharmacological 64 
applications due to the well established role of antifolates within the pharmacopoeia of 65 
antimicrobial and anticancer treatment. Thus, exploring the metabolism of folates could offer 66 
venues to intervene and modify the phenotypic traits which facilitate microbial survival to 67 
antibiotics. 68 
 69 
This study reports measurable levels of antibiotic persisters from the early exponential phase 70 
of bacterial growth. The E. coli folate gene knockout mutant which is lacking in 5-FCL (Δfau) 71 
presented lower levels of persisters in comparison to its reference isogenic strain BW25113.  72 
Next, we sought to determine if this effect could be observed by exposing fully functional 73 
strains to antifolate inhibitors. We found that both BW25113, as well as  known hyper-persister 74 
ΔhipA had their survival to bactericidal antibiotics reduced. Finally, by adopting an optimised 75 
assay for the comparative detection of persisters, the gene expression for two different 76 
metabolic pathways (including a group of nutrient membrane transporters) was measured. Gene 77 
expression profiles had apparent differences among the metabolic states underlying those 78 
genetic and pharmacological alterations. These findings contribute to the development of a 79 
metabolic framework of the complex cellular states where persister phenotypes arise in actively 80 
growing cell populations [15]. 81 
 82 
METHODS 83 
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Bacterial strains 84 
E. coli BW25113 (F-, Δ(araD-araB)567, ΔlacZ4787 (::rrnB-3), λ, rph-1, Δ(rhaD-rhaB)568, 85 
hsdR514) is a direct derivative of K12 (BD792) used as the parent strain for the Keio Collection 86 
of single gene knockouts [16]. E. coli JW2879-1 is isogenic to BW25113 with the gene (fau or 87 
ygfA) encoding 5-FCL deleted (F-, Δ(araD-araB)567, ΔlacZ4787 (::rrnB-3), λ, ΔygfA763 ::kan, 88 
rph-1, Δ(rhaD-rhaB)568, hsdR514). E. coli JW1500-2 is isogenic to BW25113 with the gene 89 
hipA deleted (F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ, ΔhipA728::kan, rph-1, Δ(rhaD-90 
rhaB)568, hsdR514). All three strains BW25113, JW2879-1 and JW1500-2 were procured from 91 
The Coli Genetic Stock Center. CGSC numbers 7636, 10233 and 9299, respectively. 92 
 93 
Media and Culture 94 
The liquid and solid complex media were Nutrient broth (70122, Sigma-Aldrich, UK) and 95 
Nutrient agar (70148, Sigma-Aldrich, UK), respectively. Strains were grown at 37oC. Where 96 
stated M9 media was used as minimal media [17].  Liquid cultures were aerated by shaking in a 97 
water bath. Every assay reported here commencedwith different fresh cultures from frozen 98 
bacterial stocks. Cultures seeded with frozen stocks were incubated typically in 5 mL of culture 99 
for 6 to 8 hours under selective antibiotic pressure when appropriate (Δfau and ΔhipA). These 100 
cultures were then diluted 1000-fold in fresh media and incubated overnight. The following day 101 
cultures were diluted in fresh media at the same ratio again and used as fresh inocula left to 102 
grow up to the desired cell density (OD600). 103 
 104 
Antibiotics 105 
Ofloxacin (Sigma O8757), ampicillin (Sigma A9518), and trimethoprim (TMP) (Sigma T7883) 106 
were dissolved in H2O at stock concentrations of 50 mg/mL. Kanamycin (Sigma K1377) was 107 
dissolved in H2O at 10 mg/mL, and sulfamethoxazole (SMX) (Sigma S7507) was dissolved in 108 
10 % v/v dimethylsulfoxide (DMSO, Sigma 472301) at 50 mg/mL. 109 
 110 
Growth curves 111 
Fresh inocula were normalised to OD600 = 0.01 in fresh broth and cultured in 96-multiwell 112 
plates in 0.2 mL. The absorbance at OD600 was registered for 24 hours in a Thermo VarioSkan 113 
microplate reader (Thermo Fisher Scientific, MA, USA). For the three-hour growth assay 114 
overnight cultures were normalised to OD600 = 0.1 in 5 mL of fresh broth and aliquoted into as 115 
many samples as time points. 116 
 117 
Antibiotic inhibitory concentrations 118 
E. coli strains were pre-cultured as detailed in Media and Culture. Final cultures in either 119 
minimal or complex media were normalised to OD600 = 0.01 by triplicate in 96-well 120 
microplates. Antibiotics were present in four-fold dilutions. Growth controls were in triplicate 121 
samples without antibiotics. Background controls were included containing 5 mg/L of 122 
ofloxacin. 123 
 124 
Three-hour persister assay 125 
Fresh inocula were normalised at OD600 = 0.1 in 5 mL of fresh broth. Different samples were 126 
withdrawn from incubation at the following time points: 0, 0.25, 0.5, 1, 2 and 3 hours. Then 127 
either ampicillin at a final concentration of 100 mg/L or ofloxacin at 5 mg/L were added to each 128 
sample and incubated overnight (16-18 hours). All the different samples were then serially 129 
diluted 1:10 in 0.2 mL of 10 mM of MgSO4 in 96-well microplates. Aliquots of 0.1 to 0.2 mL 130 
were plated out on media agar plates and incubated overnight for determination of colony-131 
forming units (cfu) [18]. Where low number of persisters were expected (e.g., assays minimal 132 
media) the culture volumes were scaled up to obtain a minimal of approximately ten colonies 133 
per agar plate. 134 
 135 
Three-hour antifolate assay 136 
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Fresh inocula were normalised to OD600 = 0.1 in 5 mL of fresh media. Either DMSO (0.1 % 137 
v/v), sulfamethoxazole (57.4 mg/L) or trimethoprim (1.7 mg/L) were added, final 138 
concentrations within parenthesis. These concentrations correspond to the reported steady-state 139 
mean levels of these two antifolates in human plasma during oral administration of Bactrim™ 140 
[19]. Samples were withdrawn from incubation at time points (in hours) 0, 0.25, 0.5, 1, 2 and 3. 141 
Aliquots of 1.5 mL from each samples were washed twice in fresh complex or minimal media. 142 
Samples were normalised to the lowest OD600 in 1 mL of media. Then ampicillin at final 143 
concentration of 100 mg/L or ofloxacin at 5 mg/L were added to each sample and incubated 144 
overnight (16-18 hours). All the different samples were then serially diluted 1:10 in 0.2 mL of 145 
fresh media in 96-well microplates. Aliquots of 0.1 mL were plated out on media agar plates 146 
and incubated overnight for determination of cfu. 147 
 148 
Real-Time PCR gene expression analysis 149 
Real-Time PCR (RT-PCR) workflow was carried out, taking into consideration the MIQE 150 
(Minimum information for publication of quantitative real-time PCR experiments) guidelines 151 
[20]. The E. coli BW25113 genome sequence [21] (GenBank accession number CP009273) was 152 
used to design PCR primers (Supplementary Table 16). Three different references genes were 153 
used: cysG, hcaT and idnT [22]. E. coli total RNA was extracted with PureZol (7326890, 154 
BioRad, UK) following the manufacturer’s recommendations. The quality and quantity of RNA 155 
were assessed in the 2100 Bioanalyzer (Agilent Technologies, Santa Cruz, CA). Synthesis of 156 
cDNA was performed with iScript (Biorad, UK) in 0.02 mL reactions scaled up when required 157 
up to 0.12 mL. Amplification reactions were set up in 0.01 mL using SsoAdvanced Universal 158 
SYBR Green Supermix (Biorad, UK) following manufacturer’s recommendations. PCR 159 
reactions were distributed in Hard Shell low profile skirted 96-well microplates sealed with 160 
Microseal B films (Biorad, UK). Amplification reactions (0.01 mL) were carried out in a 161 
CFX96 Real-Time System thermocycler (Biorad, UK), with the results compiled and 162 
automatically analysed at source with the CFX Manager software (Biorad, UK). The data 163 
presented represent three different biological replicates (n=3). Plated samples also included 164 
eight 6-fold dilutions of cDNA, with a known amount of DNA and using primers for cysG, for 165 
the generation of a standard curve. This allowed quantitation of gene amplification within each 166 
plate. Amplification efficiency was measured to assess the reproducibility of the amplification 167 
for each gene. Quantitative comparative gene amplifications was carried with normalised 168 
detection values and used to generate the fold changes as log ratios with change p-values 169 
(Supplementary Tables 17 - 19). The analysed data were compiled and plotted as heatmaps 170 
using heatmap2, which is a part of R’s gplots [23]. 171 
 172 
Statistical analysis 173 
Numerical analysis and graphical production were performed using R [23]. Antibiotic inhibitory 174 
concentrations were calculated with the dose-response analysis R extension package drc [24]. 175 
Principal Components Analysis (PCA) was conducted using the R packages FactoMineR and 176 
Factoextra [25] 177 
RESULTS 178 
Persistence to antibiotics is a phenotypic stochastic phenomenon that arises at low frequency in 179 
fresh media [26]. However, certain genetic backgrounds, such as the hyper-persister toxin hipA 180 
mutant [27, 28] or the altered gene expression of certain genes [8] have been shown to influence 181 
the frequency of persisters. An example of the latter is the decrease in the rate of persisters 182 
under low expression of the gene that encodes for the folate enzyme 5-FCL [8]. The E. coli gene 183 
knockout strains Δfau and ΔhipA and their isogenic parental strain (BW25113) were used 184 
throughout this work.  Thus, we first measured the sensitivity of these three strains to each of 185 
the different antibiotics used in this study in both complex and minimal media. Expectedly,  186 
there were high inhibitory concentrations (IC50) of SMX in the complex media and the folate 187 
knockout strain Δfau was comparatively more sensitive to SMX in the minimal media (Table 1, 188 
Supplementary Figs. 1 and 2). 189 
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 190 
Importantly, the concentrations of ampicillin and ofloxacin used for the selection of persisters 191 
were above the IC50 observed for these strains.  Also, the concentrations of antifolates (with the 192 
exception of SMX in complex media) used here were above the inhibitory concentrations (Table 193 
1). Significantly, the inhibitory concentrations of antifolates in vitro were not decisive for the 194 
concentrations of antifolate to use in the persister assays.  We sought to measure the effect of 195 
antifolates at concentrations in line with to the steady-state levels found in human plasma during 196 
treatment with oral formulation of SMX and TMP [19]. 197 
 198 
Growth rates 199 
We were primarily interested in studying persisters arisen under non apparent stress (i.e., cells 200 
in logarithmic growth in fresh media), also known as Type II persisters [3], given the known 201 
phenotypic diversification in growth rate [29] and cell mass [30] in the logarithmic phase which 202 
we hypothesise can be relevant to persister formation. However, and in contrast to previous 203 
investigations [8, 27, 28], it was found that the growth rate in Δfau and ΔhipA was different to 204 
the parental strain, BW25113, in a time and media-dependent fashion (Fig. 1). It was deemed 205 
necessary to establish incubation times that allowed observations to be made without visible 206 
differences in growth rate. Batch cultures were followed throughout 3 hours with a starting 207 
OD600 = 0.1,  optimised to allow the retrieval of cells growing logarithmically in either complex 208 
or minimal media (Fig. 1). Noticeably, the generation time approximately doubled in the 209 
minimal media (1.5 ± 0.13 hours), in comparison to bacteria which grew in the complex media 210 
(0.66 ± 0.07 hours) for all three strains (Fig. 1). Importantly, within this time window and at the 211 
observed cell densities no differences in growth rates among strains were observed, independent 212 
of the type of media and the cell counts per unit of OD600 were comparable among strains, 213 
BW25113 (95% CI 4.9 - 5.1 x 108 cells),  Δfau  (95% CI 4.9 - 5.2 x 108 cells) and  ΔhipA  (95% 214 
CI 5.0 - 5.15 x 108 cells). 215 
 216 
Biphasic response to ampicillin and ofloxacin 217 
Low-level-persistence phenotypes are usually observed as biphasic responses to antibiotics. At a 218 
OD600 = 0.3, both the reference and the folate mutant strains displayed a time-dependent killing 219 
level of persisters which stabilised after 6 hours of incubation in ampicillin in either complex or 220 
minimal media (Fig. 2). The folate mutant continued to show a decrease of persisters to 221 
ampicillin in complex media after 6 hours.  At 16 hours we measured the incidence of persisters 222 
to ampicillin at 95% CI 320 - 400 cfu per 108 cells for BW25113 and at 95% CI 56  - 80 per 108 223 
cells for  Δfau.   A similar pattern, but with fewer persisters, was seen for ofloxacin in BW25113  224 
(95% CI 8  - 20 per 108 cells) and Δfau (95% CI 4  - 8 per 108 cells). In minimal media levels of 225 
persisters were equivalent to single digits per millilitre (Fig. 2, Supplementary Table 2).  Thus, 226 
follow-up experiments in minimal media were carried scaling up culture volumes to obtain the 227 
equivalent to a minimum of ten colonies per agar plate to calculate cfu per millilitre (cfu/mL). 228 
 229 
Rate of persistence in cells in logarithmic growth (the 3-hour assay) 230 
The  appearance rate of persisters is presented as ratios of cfu/mL from a given batch culture at 231 
each time over the cfu/mL of the batch culture at time zero. This normalises the persister 232 
phenotypes related to the physiological status of the inoculates at the starting point. By three 233 
hours in complex media BW25113 had twice more persisters to ampicillin than Δfau (Fig. 3a). 234 
BW25113 presented again more persisters to ofloxacin than Δfau, this time by near a five-fold 235 
difference (Fig. 3b).  Remarkably, the number of persisters for either strain increased 236 
consistently from their lag phase and along their growth in exponential phase. An observation in 237 
line with the reported active generation of persisters to antibiotics in rapidly growing E. coli 238 
[15]. In sharp contrast, the ratio of persisters in the minimal media for BW25113 and Δfau 239 
declined throughout, and were closed to zero by 3 hours. This applied to both, bacteria exposed 240 
to ampicillin (Fig. 3c) and ofloxacin (Fig. 3d). The metabolic network of cells in minimal media 241 
was clearly incompatible with the necessary metabolic state required for the phenotypic 242 
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diversification that drives persistence. 243 
 244 
The effect of antifolates on the reference strain BW25113 245 
It was considered relevant to study how the results presented thus far compared with the 246 
behaviour of the bacteria following administration of pharmacological inhibitors of folate 247 
biosynthesis, and how this affected the development of antibiotic persisters. In the absence of 248 
validated inhibitors of 5-FCL it was deemed cogent to use two well established antimicrobial 249 
antifolates: sulfamethoxazole (SMX) and trimethoprim (TMP).  Inhibitors of the de novo folate 250 
biosynthesis enzyme dihydropteorate synthetase, and the OCFM enzyme dihydrofolate 251 
reductase, respectively. The BW25113 strain was incubated for up to three hours using each of 252 
these antifolates or DMSO as the control for the solvent used for SMX. As expected, growth 253 
was affected by TMP in the complex media and by both SMX and TMP in the minimal media 254 
(Figs. 4a and 4d).  Therefore, samples had to be normalised based on their optical densities to 255 
the sample with the least cell mass per volume. Thereafter, cultures were exposed overnight to 256 
either ampicillin or ofloxacin. 257 
 258 
Incubation with TMP in complex media repressed the development of persisters to both 259 
ampicillin and ofloxacin (Figs. 4b and 4c). The effect of SMX is not apparent for ampicillin but 260 
interestingly it appear to have reduced persisters to ofloxacin after two hours (Fig. 4c). Bacteria 261 
in minimal media was still affected by the incubation in SMX given the lower ratio of persister 262 
for ampicillin than in the solvent control and TMP (Fig. 4e). The ratios of persisters for 263 
ofloxacin were reduced by TMP and less so by SMX in comparison to DMSO (Fig. 4f). On the 264 
other hand, it seems that 0.1 % DMSO was sufficient to cause a noticeable drop, by 265 
approximately an order of magnitude, in the ratio of persisters by three hours (Figs. 4b and 4c) 266 
in comparison to the levels observed before in complex media (Figs. 3a and 3b). Nonetheless, 267 
and particularly for TMP in complex media, the number of persisters quantified by three hours 268 
of incubation in this antifolate allowed us to detect 10-fold and 50-fold less persisters than in the 269 
control for ampicillin and ofloxacin, respectively (Figs. 4b and 4c). In minimal media TMP 270 
showed a 10-fold difference in comparison to the control for ofloxacin (Fig. 4f).  Thus, in 271 
complex media TMP seems to reduce the number of persisters to ampicillin and ofloxacin while 272 
in minimal media TMP causes mainly a visible, though lesser, reduction in ofloxacin persisters. 273 
 274 
The effect of antifolates on the hyper-persistent mutant strain ΔhipA 275 
By the very nature of the stochasticity of phenotypic diversification, microbes are likely to be in 276 
a broad spectrum of physiological states while growing logarithmically. It was reasoned 277 
important to investigate the response to antifolates from a strain prone to develop persisters by 278 
using the knockout mutant of toxin hipA (ΔhipA), a well known hyper-persister [27, 28].  In 279 
contrast to   SMX, TMP had a discernible inhibition on the growth of ΔhipA (Fig. 5a).  280 
Subsequently, TMP showed to have a clear suppressing effect on the ratio of persisters in ΔhipA 281 
in complex media for both ampicillin (approximately 50-fold reduction) and ofloxacin 282 
(approximately 500-fold reduction) (Figs. 5b and 5c), in a trend not dissimilar to the effects on 283 
the parental strain (Figs. 4b and 4c).  In minimal media both SMX and TMP reduced the growth 284 
rate of ΔhipA (Fig. 5d). Both antifolates also reduced the ratios of persisters in this media for 285 
ampicillin and ofloxacin (Figs. 5e and 5f), with a more pronounced reduction in persister levels 286 
for ofloxacin (Fig. 5f). 287 
 288 
The impact of Antifolates on persister development: Principal Components Analysis 289 
Principal Components Analysis (PCA) was used to summarise the data gathered for the effects 290 
of antifolates BW25113 and ΔhipA. Data were organised as listed in the Supplementary Table 291 
15: presence of antifolates,  type of antibiotic (ampicillin or ofloxacin), strain (BW25113 or 292 
ΔhipA), time spent in antifolates (0 - 3 hours), media (complex or minimal), and ratio of 293 
persisters (cfu/mL at a given time up to 3 hours over cfu/mL at time zero). The first two 294 
dimensions made up approximately 41% of the total variance of the dataset (inertia) (Fig. 6). 295 
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The variables type of antibiotic and the  time spent in antifolates were correlated positively to 296 
the ratio of persisters. This was a key finding, as it suggested persister development was 297 
associated with the type of antibiotic (ampicillin or ofloxacin) in agreement with the literature, 298 
but also here in relation to the time spent in the antifolates. The variables media and the type of 299 
antifolates were negatively correlated to the ratio of persisters, indicating that in either media 300 
either antifolate seemed to lower the incidence of persisters (Fig. 6). Notably, the variable strain, 301 
the reference strain BW25113 or the hyper-persister ΔhipA, behaved as a supplementary (i.e., 302 
non-active) variable. This suggested antifolates had a similar effect on both of these strains. 303 
That is to say the hyper-persister strain as susceptible as the reference strain to the effects  of 304 
antifolates.  An encouraging finding for clinically relevant settings.   305 
 306 
The gene expression profile of the reference strain BW25113 in exponential growth 307 
It was logical to investigate the molecular basis for the development of persisters in the 308 
reference E. coli strain. A methodology was developed to use optimised targeted RT-PCR 309 
amplifications to profile the gene expression responses of the parental E. coli strain, BW25113 310 
throughout the 3-hour growth assay in the complex media (Fig. 1c). Data were analysed and 311 
interpreted by comparing the gene expression levels at different time points against the initial 312 
samples (time zero).  Cells that grew within this time frame displayed the persistence 313 
phenotypes associated with both ampicillin and ofloxacin (Figs. 3a and 3b). The set of genes 314 
which were queried encode for folate biosynthesis and usage (OCFM) pathways, fifteen solute 315 
transporters, twelve fatty acids biosynthesis enzymes, and the cydX gene (subunit X of 316 
cytochrome d (bd-I) ubiquinol oxidase) (Supplementary Table 16). Also included were fatty 317 
acid biosynthesis genes which have been shown to be involved in the development of persisters 318 
[31]. 319 
On the other hand, oxidative phosphorylation, represented here by cydX, has been shown to 320 
sensitise bacteria to antibiotics [32]. Consistently, cydX was underrepresented in exponential 321 
growth phase, along the generation of persisters (Figs. 3a, 3b and 7). This is in agreement with 322 
glycolysis being the main source of cell mass and energy in rapid cell growth with the flux 323 
control for this pathway originating mainly from ATP utilisation due to the fact that the majority 324 
of the control of growth rate resides in the anabolic reactions [33]. 325 
 326 
Folate biosynthesis represented by folC, pabC, aroH and folP appeared to be active through 327 
the initial hour of growth in fresh complex media (Fig. 7). Only the gene expression of the 328 
transporters of amino acids and pantothenate, putP and panF, seem to have increased before the 329 
initial hour. After the first hour, the expression of genes representing other enzymes of folate 330 
biosynthesis as well as nine more substrate membrane transporters seemed to have increased 331 
(cycA, shiA, citT, nupC, dsdX, nupG, aroP, glcA, and uhpT) (Fig. 7).  332 
 333 
The comparative gene expression profile of the folate mutant strain Δfau in exponential 334 
growth 335 
We assessed the genetic expression profile of the gene knockout folate mutant Δfau in 336 
comparison to BW25113. The initial outline at time zero showed the majority of genes 337 
underexpressed with three genes overexpressed in Δfau cells, all three solute membrane 338 
transporters (gadC, uhpT, citT) involved in the uptake of organic acids and carbohydrates (Fig. 339 
8). During the first hour there was an apparent overexpression of genes that included the glycine 340 
cleavage complex (GCV) of the OCFM (lpdA, gcvH, gcvP, gcvT), whose gene expression 341 
pattern clustered with the proline:Na symporter putP. The time points at two and three hours 342 
(Fig. 8) gave an indication of the potential overexpression of a number of genes involved in 343 
encoding lipogenesis enzymes.  The majority of solute membrane transporters targeted here 344 
were overexpressed by the second or third hour (shiA, nupG, gadC, nupC, cycA, panF, uhpT, 345 
glcA, aroP, citT, adeQ, and dsdX). Altogether, folate metabolism in the folate mutants was 346 
underrepresented, while lipogenesis, and a number of solute membrane transporters seem to 347 
have been overrepresented. 348 
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 349 
The comparative gene expression profile of the bacteria exposed to trimethoprim 350 
In the complex media only TMP was found to alter the incidence of persisters to ampicillin and 351 
more significantly to ofloxacin (Fig. 4). BW25113 cells treated with TMP had initially a 352 
discrete number of overrepresented genes encoding folate metabolism and lipogenesis together 353 
with two membrane transporters (aroP and adeQ) (Fig. 9).  After one hour,  the over-expression 354 
of genes encoding for folate metabolism (particularly OCFM) and lipogenesis became more 355 
apparent (Fig. 9). Similarly, five solute membrane transporters were expressed after the first 356 
hour (cycA, pnuC, panF, adeQ, and nupG).  Contrary to the Δfau gene knockout strain, the 357 
response to antifolate treatment seems to have included a representation of folate biosynthesis 358 
(Figs. 8 - 9). 359 
  360 
DISCUSSION 361 
 362 
The evidence presented here connects folate metabolism to the generation of persisters to 363 
antibiotics in exponentially growing bacteria. Antibiotic persisters were described soon after the 364 
discovery of penicillin [34] and subsequently observed across different forms of drug tolerance 365 
in human pathogens [3, 4, 35]. However, it is unknown how sub-populations of microorganisms 366 
survive environmental stressors and qualify as persisters. In an attempt to conceptualise this 367 
phenomenon some have called persistence a consequence of dormancy or latency.  Here, we are 368 
avoiding these terms which may not necessarily convey the physiology of cells in rapid growth 369 
that happen to survive a given stressor [15, 36]. In cells under low nutrient levels (i.e., bacteria 370 
in spent media), the development of persisters to antibiotics is three to four orders of magnitude 371 
higher than in a population in fresh media [37, 38]. This has been rationalised under the known 372 
cell responses that takes place under scarcity of nutrients [39].  However, bacteria viable after 373 
exposure to antibiotics are also observed in steady-state growth (Type II persisters) before 374 
shortage of nutrients becomes significant (e.g., stationary phase in batch culture) [15, 40, 41]. 375 
Here, we have observed that E. coli with either genetically or pharmacologically impaired folate 376 
metabolism, presented low levels of persisters. This is a counterintuitive finding since 377 
interrupting anabolic metabolism and slow cell growth (i.e., exposure to bacteriostatics such as 378 
antifolates) is expected to increase the level of persisters [1 - 3]. 379 
 380 
We observed that persisters to antibiotics are detectable from the moment bacteria leave the 381 
lag phase in complex media. A trend that continues along the logarithmic growth (Fig. 3).  This 382 
is an observation in agreement with previous findings [15]. We propose that the source of the 383 
phenotypic variability, a requirement for the appearance of persisters, could be explored under 384 
the known cell to cell heterogeneity intrinsic to rapid cell growth. Namely, cell to cell and 385 
within cell gene expression variability [42], variability in DNA and protein contents [43], as 386 
well as cell size variability [30].  On the other hand, the functions of folate cofactors involve 387 
providing carbon units to anabolic pathways for DNA biosynthesis, methionine biosynthesis, 388 
and NADPH production [14, 44].  Consequently, antifolates such as TMP produce cellular stasis 389 
and death by reducing cellular levels of the pyrimidine thymidine which desarranges DNA 390 
replication and triggers a futile cycle of DNA damage and repair (“thymineless death”) [45].  At 391 
this point the basis of our findings become more apparent since interfering with folate 392 
metabolism reduces the concentration of metabolites required for such key anabolic processes 393 
directly linked to cell growth. Consistent with this, the gene encoding carbamoyl phosphate 394 
synthetase (involved in the de novo biosynthesis of pyrimidines) has been singled out in a recent 395 
genetic scan where its loss of function mutant reduced thousands-fold the generation of 396 
persisters to antibiotics in bacteria [46]. 397 
 398 
Supporting the above, batch cultures of the reference strain in minimal media at cell 399 
densities equivalent to that in complex media showed significantly less persisters to either 400 
ampicillin or ofloxacin by approximately two orders of magnitude (Figs. 2 and 3). We interpret 401 
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this as a consequence of reduced metabolite availability which has an impact on the rate of 402 
anabolism necessary for cell growth and multiplication (e.g., DNA replication, transcription, 403 
protein biosynthesis, ribosomal mass). For instance, disarrayed replication forks under scarcity 404 
of pyrimidines and the deleterious effects of uracil incorporation into DNA from thymidine-405 
deficient nucleotide pools induces a low frequency of initiation of the replication cycle and 406 
origin-proximal DNA degradation during thymine starvation [45]. The reduction of metabolites 407 
that impact cell growth limits the phenotype landscape from which persisters arise. Under 408 
abundant nutrients the stochastic differences among individuals in, for instance, rate of 409 
processes such as DNA initiation and elongation, would provide a broad phenotypic diversity. 410 
Contrarily, under limited sources a low metabolic flux would only sustain low anabolic rates 411 
that attenuates intracellular and intercellular stochastic effects. 412 
 413 
In complex media specific nutrient transport into the cell becomes advantageous and 414 
membrane transport has been shown to be part of the development of persisters [47, 48]. The 415 
results of this investigation seem to suggest that  certain substrate membrane intake occurs along 416 
logarithmically growing bacteria (Figs. 7 - 9). Several studies have used experimental 417 
antimetabolites to ameliorate the appearance of bacterial persisters [49, 50, 51, 52, 53, 54]. A 418 
great advantage of antimetabolites such as antifolates is the fact that they are licensed 419 
antimicrobials in clinical practice and have been so for eight decades.  Although new antifolates 420 
have been added to the cancer chemotherapy pipeline [55], the development and deployment of 421 
new antifolates as antimicrobials lags significantly behind [56].  Nonetheless, evidence 422 
continues to support the repurposing of antifolates in the treatment of infectious diseases, 423 
including those where resistance has become widespread [57, 58, 59].  It is encouraging to have 424 
found that antifolates affected a known hyper-persister E. coli strain as much as the reference 425 
strain.  This is of relevance for the clinical scenarios where it is likely to find a range of persister 426 
levels in active infections.  If the appearance of phenotypic variants that persist to antibiotics is 427 
closely coupled with the dynamics of exponential generation of cellular mass in E.  coli, folate 428 
metabolism would have a role in the cellular metabolism underlying such variability.  429 
Therefore,  antifolates could offer a potential avenue for assisting in improving the success of 430 
current bactericidal antibiotic treatments. 431 
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Figure legends 641 
15 of 17 
Fig. 1. Growth rates. Bacterial growth was followed for 24 hours in either complex media (a) or 642 
minimal media (b).  BW25113 denotes the reference strain, and Δfau and ΔhipA the gene 643 
knockout strains for the folate gene fau and the toxin gene hipA, respectively.  Bacterial growth 644 
was also followed for 3 hours in either complex media (c) or minimal media (d). The Y-axes 645 
represent the optical density (OD600) with a starting OD600 = 0.1. The means and standard 646 
deviations for three different experiments (n = 3) are shown. 647 
Fig. 2. Biphasic time-dependent killing.   Cultures were grown to an OD600 = 0.3 before adding 648 
either ampicillin (100 mg/L) or ofloxacin (5 mg/L) in complex media (a) or minimal media (b) 649 
for the indicated times.  Samples collected at a given time were diluted and spread plated on LB 650 
agar.  The experiments were performed in triplicate (n=3). Data compiled in the Supplementary 651 
Tables 1 and 2. 652 
Fig. 3. The incidence of persisters in the folate gene knockout strain in complex media. Bacteria 653 
were exposed for 16 hours to ampicillin 100 mg/L (a) or ofloxacin 5 mg/L (b), after growing in 654 
complex media for different durations (0, 0.25, 0.5, 1, 2 and 3 hours). Bacteria in minimal 655 
media were also exposed to ampicillin 100 mg/L (c) or ofloxacin 5 mg/L (d). The left Y-axes 656 
show the optical density of the cultures and the right Y-axes show the ratios (versus time zero) 657 
of persisters after two hours of incubation in either antibiotic. Data compiled in the 658 
Supplementary Tables 3 - 6. 659 
Fig. 4. The effects of antifolates on persistence to antibiotics in the reference strain BW25113. 660 
(a) Bacteria in complex media in the presence of either 0.1% (v/v) dimethylsulfoxide (DMSO), 661 
1.7 mg/L trimethoprim (TMP), or 57.4 mg/L sulfamethoxazole (SMX).  At different time points 662 
(0, 1, 2, and 3 hours) the cultures were washed, resuspended in complex media and incubated 663 
for 16  hours in the presence of either antibiotic, ampicillin 100 mg/L (b) or ofloxacin 5 mg/L 664 
(c).  Incidence of persister is shown as a ratio of cfu/mL from each time point over time zero. 665 
(d) Bacteria in minimal media in the presence of either 0.1% (v/v) dimethylsulfoxide (DMSO), 666 
1.7 mg/L trimethoprim (TMP), or 57.4 mg/L sulfamethoxazole (SMX).  At different time points 667 
(0, 1, 2, and 3 hours) the cultures were washed, resuspended in minimal media and incubated for 668 
16 hours in the presence of ampicillin 100 mg/L (e) or ofloxacin 5 mg/L (f). Incidence of 669 
persister is shown as a ratio of cfu/mL from each time point over time zero.  Data compiled in 670 
Supplementary Tables 7 - 10. 671 
 672 
Fig. 5. The effects of antifolates on the persistence to antibiotics in the hyper-persister strain 673 
ΔhipA.  (a) Bacteria in complex media in the presence of either 0.1% (v/v) dimethylsulfoxide 674 
(DMSO), 1.7 mg/L trimethoprim (TMP), or 57.4 mg/L sulfamethoxazole (SMX).  At different 675 
time points (0, 1, 2, and 3 hours) the cultures were washed, resuspended in complex media and 676 
incubated for 16 hours in the presence of either antibiotic, ampicillin 100 mg/L (b) or ofloxacin 677 
5 mg/L (c). The incidence of persisters is shown as a ratio of cfu/mL from each time point over 678 
time zero. (d) Bacteria in minimal media in the presence of either 0.1% (v/v) dimethylsulfoxide 679 
(DMSO), 1.7 mg/L trimethoprim (TMP), or 57.4 mg/L sulfamethoxazole (SMX). At different 680 
time points (0, 1, 2, and 3 hours) the cultures were washed, resuspended in minimal media and 681 
incubated for 16 hours in the presence of ampicillin 100 mg/L (e) or ofloxacin 5 mg/L (f). The 682 
incidence of persisters is shown as a ratio of cfu/mL from each time point over time zero. Data  683 
compiled in the Supplementary Tables 11 - 14. 684 
 685 
Fig. 6. Principal Components Analysis for the effect of antifolates on the development of 686 
persisters. The dataset on antifolates was summarised with six different variables: strain 687 
(BW25113 or ΔhipA), time exposure to antifolates (in hours), antifolate (DMSO, SMX, TMP), 688 
media (minimal media or complex media), antibiotic (ampicillin or ofloxacin), and level of 689 
persisters (the ratio of cfu/mL at each time point in antifolates over the cfu/mL at time zero). 690 
The X-axis represents the principal component 1, and the Y-axis represents the principal 691 
component 2. Distances from zero represent the magnitudes of the effects of each variable. The 692 
associated ranks in order to carried out the PCA are in Supplementary Table 15. 693 
 694 
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Fig. 7. Gene expression in the reference strain (BW25113) during the three-hour growth assay 695 
in complex media. The levels of gene expression, at the specified time points (in hours), as a 696 
ratio of the values at time zero. The yellow column at the initial time point denotes no 697 
differences in gene expression since this the ratio of gene expression levels in this sample 698 
against itself. Colour keys for the metabolic pathways which were studied are to the left of the 699 
heatmap (respiration gene cydX denoted by the black colour key) and the gene list is to the right. 700 
 701 
Fig. 8. Comparative differential gene expression in the folate mutant strain. The levels of gene 702 
expression, at the specified time points (in hours), in the folate knockout mutant Δfau strain 703 
compared to the reference strain BW25113. Colour keys for the metabolic pathways which were 704 
studied are to the left of the heatmap (respiration gene cydX denoted by the black colour key) 705 
and the gene list is to the right. 706 
 707 
Fig. 9. Gene expression in the reference strain (BW25113) in the presence of trimethoprim. 708 
Gene expression, at the specified time points (in hours), in the BW25113 strain incubated in 709 
trimethoprim (1.7 mg/L) when compared to the untreated BW25113 control. The yellow column 710 
at the initial time point denotes no differences in gene expression at the moment of adding the 711 
antifolate. Colour keys for the metabolic pathways which were studied are to the left of the 712 
heatmap (respiration gene cydX denoted by the black colour key) and the gene list is to the right. 713 
 714 
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Tables 715 
 716 
Table 1. The inhibitory concentrations of antibiotics and the solvent (DMSO) used in this study. 717 
All three strains of E. coli are included. BW25113 is the parental strain, Δfau is the folate 718 
mutant strain, and ΔhipA is the hyper-persister strain. Data represent inhibitory concentrations 719 
as IC50 in mg/L, except for DMSO which is in % (vol/vol). 720 
 Minimal media Complex media  
 BW25113 Δfau ΔhipA BW25113 Δfau ΔhipA Used 














































349 ± 8.55 141 ± 2.83 2383 ± 262 57.4 
 721 
 722 
Additional Files 723 
Additional file 1 — Inhibitory concentration curves in minimal media of antibiotics and DMSO 724 
on the E. coli strains used in this study. 725 
Additional file 2 — Inhibitory concentration curves in complex media of antibiotics and DMSO 726 
on the E. coli strains used in this study. 727 
Additional file 3 — Supplementary tables 1 to 16 728 
Additional file 4 — Supplementary table 17 gene expression BW25113 729 
Additional file 5 — Supplementary table 18 gene expression fau versus BW25113 730 
Additional file 6 — Supplementary table 19 gene expression TMP-treated BW25113 versus 731 
BW25113 732 
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Supplementary Table 1: Time-dependent number of persisters in complex media. Number of persister in both BW25113
and folate mutant strains (JW2879-1) growing in batch cultures for three hours with an starting OD600 = 0.1. Data in cfu/mL.
Means and standard deviations (Std) are presented for five different experiments (n=5). Ratios of number of persisters are listed
for each time point against time zero. The p-values of T-tests for data in each time point for the folate mutant versus the parental
strains are also included. Time points in hours are 0, 0.25, 0.5, 1, 2 , and 3.
Ampicillin
BW25113
Time 1 2 3 4 5 Mean Stdev Log (mean)
0 187660713 547767961 211753745 507128094 439552500 378772603 168187256 8.578
1 146076 247204 206626 179366 152424 186339 41642 5.27
2 71293 78382 79027 67072 55599 70274 9605 4.847
3 8891 11950 9330 11679 10193 10408 1369 4.017
4 3358 3002 3380 2130 3487 3071 557 3.487
5 816 1006 717 743 902 837 119 2.923
6 344 215 328 365 310 312 58.2 2.495
16 254 174 200 260 290 236 47.2 2.372
24 263 226 256 246 223 243 17.9 2.385
JW2879-1
Time 1 2 3 4 5 Mean Stdev Log (mean)
0 21051628 35801723 56170735 36038338 37670957 37346676 12490772 7.572
1 125442 71759 130950 291193 335401 190949 115122 5.281
2 14388 11317 5891 9528 27219 13669 8175 4.136
3 2438 2411 4320 2618 2974 2952 797 3.47
4 1642 1418 997 1243 1008 1262 276 3.101
5 290 593 642 138 846 502 285 2.701
6 295 294 247 216 190 248 46.6 2.395
16 115 57 144 151 129 119 37.7 2.076
24 80 42 76 91 74 72.5 18.4 1.86
Ofloxacin
BW25113
Time 1 2 3 4 5 Mean Stdev Log (mean)
0 59767537 43068468 59827576 40166785 47534924 50073058 9257081 7.7
1 60414 60693 63551 86996 50570 64445 13530 4.809
2 242 303 365 131 401 289 107 2.46
3 59 35 68 116 120 79.7 37.4 1.902
4 16 48 30 43 7 28.8 17.5 1.459
5 18 11 14 35 37 23 12.2 1.361
6 5 20 7 25 50 21.6 17.9 1.334
16 18 14 23 29 30 22.8 6.79 1.357
24 15 16 47 37 6 24.2 17.3 1.384
JW2879-1
Time 1 2 3 4 5 Mean Stdev Log (mean)
0 22298113 20176444 29232841 29075816 36491388 27454920 6461713 7.439
1 223 175 165 145 224 186 35.7 2.27
2 13 28 12 16 14 16.8 6.52 1.226
3 15 16 25 18 11 17 5.17 1.232
4 21 17 10 23 21 18.4 5.05 1.265
5 25 15 20 21 18 19.8 3.75 1.296
6 11 23 18 17 17 17.3 4.15 1.239
16 18 18 12 22 21 18.2 3.93 1.26
24 16 17 15 22 18 17.7 2.49 1.248
Supplementary Table 2: Time-dependent number of persisters in minimal media. Number of persister in both BW25113
and folate mutant strains (JW2879-1) growing in batch cultures for three hours with an starting OD600 = 0.1. Data in cfu/mL.
Means and standard deviations (Std) are presented for five different experiments (n=5). Ratios of number of persisters are listed
for each time point against time zero. The p-values of T-tests for data in each time point for the folate mutant versus the parental
strains are also included. Time points in hours are 0, 0.25, 0.5, 1, 2 , and 3.
Ampicillin
BW25113
Time 1 2 3 4 5 Mean Stdev Log (mean)
0 10293805 10224679 10885937 9047462 11141440 10318665 809964 7.014
1 15721 13384 23705 26946 18953 19742 5586 4.295
2 1591 1616 975 1040 902 1225 349 3.088
3 116 137 139 145 41 116 43.3 2.063
4 13 11 13 21 14 14.7 3.77 1.166
5 2 3 2 1 1 1.76 0.75 0.245
6 3 1 2 2 2 2.08 0.43 0.318
16 2 3 1 2 3 1.97 0.76 0.295
24 2 2 3 2 2 2.02 0.45 0.305
JW2879-1
Time 1 2 3 4 5 Mean Stdev Log (mean)
0 3663221 2769499 1760461 2914497 554138 2332363 1203153 6.368
1 10012 17361 18407 11204 11302 13657 3909 4.135
2 1092 411 1250 930 1516 1040 413 3.017
3 32 91 101 116 53 78.6 34.8 1.896
4 3 6 5 7 5 5.09 1.41 0.707
5 1 1 2 1 1 1.42 0.61 0.153
6 1 1 2 2 1 1.46 0.51 0.165
16 1 2 1 2 1 1.51 0.36 0.18
24 1 1 2 2 2 1.48 0.44 0.169
Ofloxacin
BW25113
Time 1 2 3 4 5 Mean Stdev Log (mean)
0 4101128 3179671 4127221 2675466 4002861 3617269 655999 6.558
1 6944 7789 6903 5291 8216 7029 1122 3.847
2 18 38 23 19 7 21.2 11.2 1.326
3 7 4 6 5 5 5.27 1.35 0.722
4 3 3 3 3 1 2.51 1.07 0.399
5 1 3 2 3 3 2.32 0.65 0.365
6 2 2 2 3 3 2.37 0.36 0.375
16 4 3 2 1 2 2.37 1.06 0.375
24 2 2 1 2 2 1.72 0.69 0.235
JW2879-1
Time 1 2 3 4 5 Mean Stdev Log (mean)
0 2307456 3906190 1958115 3223489 5412309 3361512 1378591 6.527
1 24 13 11 15 17 15.9 5.05 1.2
2 1 1 1 1 2 1.22 0.25 0.088
3 1 2 2 2 1 1.57 0.31 0.195
4 2 1 2 2 2 1.56 0.33 0.194
5 1 1 1 1 1 1.23 0.23 0.089
6 2 1 2 2 1 1.54 0.5 0.187
16 1 1 1 2 1 1.35 0.28 0.131
24 2 1 1 1 1 1.22 0.41 0.088
Supplementary Table 3: The number of persisters to Ampicillin in complex media. Number of persister in both
BW25113 and folate mutant strains (JW2879-1) growing in batch cultures for three hours with an starting OD600 = 0.1. Data in
cfu/mL. Means and standard deviations (Std) are presented for five different experiments (n=5). Ratios of number of persisters
are listed for each time point against time zero. The p-values of T-tests for data in each time point for the folate mutant versus
the parental strains are also included. Time points in hours are 0, 0.25, 0.5, 1, 2 , and 3.
Complex media and Ampicillin
BW25113
0 0.25 0.5 1 2 3
1 3.83E+02 4.51E+02 9.80E+02 2.02E+03 8.77E+03 2.24E+04
2 4.60E+02 3.64E+02 8.30E+02 2.22E+03 7.77E+03 2.44E+04
3 6.00E+02 4.51E+02 1.00E+03 2.20E+03 7.54E+03 2.60E+04
4 5.30E+02 3.86E+02 9.86E+02 3.01E+03 8.54E+03 2.20E+03
5 5.32E+02 2.98E+02 9.87E+02 2.21E+03 8.54E+03 2.54E+04
Means 5.01E+02 3.90E+02 9.57E+02 2.33E+03 8.23E+03 2.01E+04
Std 8.25E+01 6.44E+01 7.11E+01 3.88E+02 5.41E+02 1.01E+04
Ratios 1.00E+00 7.78E-01 1.91E+00 4.66E+00 1.64E+01 4.00E+01
JW2879-1
0 0.25 0.5 1 2 3
1 4.60E+01 6.10E+01 8.10E+01 2.31E+02 4.90E+02 1.02E+03
2 5.40E+01 7.20E+01 9.20E+01 1.80E+02 4.51E+02 1.08E+03
3 4.80E+01 7.40E+01 8.40E+01 1.60E+02 5.45E+02 1.09E+03
4 5.80E+01 6.40E+01 7.40E+01 2.10E+02 4.67E+02 9.82E+02
5 5.80E+01 6.90E+01 7.90E+01 1.90E+02 4.91E+02 1.06E+03
Means 5.28E+01 6.80E+01 8.20E+01 1.94E+02 4.89E+02 1.05E+03
Std 5.59E+00 5.43E+00 6.67E+00 2.74E+01 3.56E+01 4.57E+01
Ratios 1.00E+00 1.29E+00 1.55E+00 3.68E+00 9.26E+00 1.98E+01
p-values 1.98E-06 3.78E-06 3.43E-09 1.78E-06 1.01E-09 2.92E-03
Supplementary Table 4: The number of persisters to Ofloxacin in complex media. Number of persister in both BW25113
and folate mutant strains (JW2879-1) growing in batch cultures for three hours with an starting OD600 = 0.1. Data in cfu/mL.
Means and standard deviations (Std) are presented for five different experiments (n=5). Ratios of number of persisters are listed
for each time point against time zero. The p-values of T-tests for data in each time point for the folate mutant versus the parental
strains are also included. Time points in hours are 0, 0.25, 0.5, 1, 2 , and 3.
Complex media and Ofloxacin
BW25113
0 0.25 0.5 1 2 3
1 2.60E+01 1.02E+02 1.50E+02 4.00E+02 1.95E+03 4.60E+03
2 1.70E+01 9.60E+01 1.32E+02 3.89E+02 1.93E+03 3.99E+03
3 1.60E+01 1.01E+02 1.89E+02 4.32E+02 1.99E+03 4.50E+03
4 1.64E+01 9.80E+01 2.01E+02 3.98E+02 1.88E+03 3.86E+03
5 1.84E+01 1.03E+02 1.98E+02 4.02E+02 1.99E+03 4.40E+03
Means 1.88E+01 9.97E+01 1.57E+02 4.07E+02 1.96E+03 4.36E+03
Std 4.15E+00 3.21E+00 2.91E+01 2.23E+01 2.65E+01 3.27E+02
Ratios 1.00E+00 5.31E+00 8.37E+00 2.17E+01 1.04E+02 2.33E+02
JW2879-1
0 0.25 0.5 1 2 3
1 3.10E+00 3.50E+00 6.50E+00 1.50E+01 5.50E+01 1.38E+02
2 2.20E+00 3.89E+00 5.89E+00 1.64E+01 7.60E+01 1.70E+02
3 2.10E+00 3.45E+00 5.45E+00 1.25E+01 7.20E+01 1.35E+02
4 2.30E+00 4.21E+00 5.32E+00 1.36E+01 5.42E+01 1.42E+02
5 2.40E+00 4.12E+00 6.12E+00 1.74E+00 5.74E+01 1.46E+02
Means 2.42E+00 3.61E+00 5.95E+00 1.46E+01 6.77E+01 1.48E+02
Std 3.96E-01 2.41E-01 5.27E-01 1.95E+00 1.12E+01 1.95E+01
Ratios 1.00E+00 1.49E+00 2.46E+00 6.05E+00 2.80E+01 6.11E+01
p-values 2.24E-05 1.35E-12 2.03E-06 2.56E-11 2.60E-13 2.66E-09
Supplementary Table 5: The number of persisters to Ampicillin in minimal media. Number of persister in both
BW25113 and folate mutant strains (JW2879-1) growing in batch cultures for three hours with an starting OD600 = 0.1. Data in
cfu/mL. Means and standard deviations (Std) are presented for five different experiments (n=5). Ratios of number of persisters
are listed for each time point against time zero. The p-values of T-tests for data in each time point for the folate mutant versus
the parental strains are also included. Time points in hours are 0, 0.25, 0.5, 1, 2 , and 3.
Minimal media and Ampicillin
BW25113
0 0.25 0.5 1 2 3
1 2.51E+01 5.77E+00 1.10E+01 8.10E+00 3.00E-01 2.80E-01
2 3.51E+01 6.50E+00 2.00E+00 9.10E+00 6.33E-01 2.00E-01
3 5.00E+00 5.00E+00 2.12E+00 8.20E+00 3.20E-01 1.00E+00
4 2.71E+01 5.10E+00 1.30E+01 8.75E+00 6.45E-01 2.20E-01
5 3.50E+00 9.00E+00 3.00E+00 2.60E+00 7.33E-01 1.10E+00
Means 1.92E+01 6.27E+00 6.22E+00 7.35E+00 5.26E-01 5.60E-01
Std 1.41E+01 1.64E+00 5.33E+00 2.69E+00 2.01E-01 4.50E-01
Ratios 1.00E+00 3.27E-01 3.25E-01 3.84E-01 2.75E-02 2.92E-02
JW2879-1
0 0.25 0.5 1 2 3
1 2.10E+01 7.25E+00 9.35E+00 3.35E+00 6.00E-01 3.75E+00
2 2.00E+01 8.20E+00 8.20E+00 6.00E+00 1.00E+00 4.85E+00
3 2.45E+01 8.30E+00 1.00E+01 1.00E+01 7.00E-01 3.62E+00
4 2.40E+01 7.65E+00 9.12E+00 5.70E+00 1.12E+00 5.00E+00
5 2.65E+01 1.08E+01 8.62E+00 1.21E+01 9.60E+00 3.96E+00
Means 2.32E+01 8.44E+00 9.06E+00 7.43E+00 2.60E+00 4.24E+00
Std 2.67E+00 1.39E+00 6.90E-01 3.54E+00 3.92E+00 6.43E-01
Ratios 1.00E+00 3.64E-01 3.91E-01 3.21E-01 1.12E-01 1.83E-01
p-values 5.49E-01 5.40E-02 2.73E-01 9.69E-01 2.70E-01 5.98E-06
Supplementary Table 6: The number of persisters to Ofloxacin in minimal media. Number of persister in both BW25113
and folate mutant strains (JW2879-1) growing in batch cultures for three hours with an starting OD600 = 0.1. Data in cfu/mL.
Means and standard deviations (Std) are presented for five different experiments (n=5). Ratios of number of persisters are listed
for each time point against time zero. The p-values of T-tests for data in each time point for the folate mutant versus the parental
strains are also included.Time points in hours are 0, 0.25, 0.5, 1, 2 , and 3.
Minimal media and Ofloxacin
BW25113
0 0.25 0.5 1 2 3
1 2.25E+00 2.94E+00 3.85E-01 2.90E-02 6.50E-02 5.80E-02
2 4.90E+00 2.50E+00 1.20E+00 8.50E-02 6.00E-02 1.05E-01
3 3.00E+00 3.00E+00 2.00E+00 1.00E-01 1.00E-01 1.00E-01
4 3.90E+00 2.70E+00 1.40E+00 9.50E-02 5.90E-02 5.90E-02
5 2.90E+00 2.80E+00 2.32E+00 1.10E-01 1.20E-01 1.15E-01
Means 3.39E+00 2.79E+00 1.46E+00 8.38E-02 8.08E-02 8.74E-02
Std 1.03E+00 1.99E-01 7.51E-01 3.19E-02 2.77E-02 2.69E-02
Ratios 1.00E+00 8.23E-01 4.31E-01 2.47E-02 2.38E-02 2.58E-02
JW2879-1
0 0.25 0.5 1 2 3
1 2.06E-01 8.10E-02 1.18E-02 4.50E-03 1.10E-03 1.60E-03
2 3.45E-01 1.35E-01 2.40E-02 1.40E-02 4.00E-03 1.70E-02
3 2.46E-01 9.10E-02 1.10E-01 5.00E-02 1.10E-02 3.00E-02
4 3.56E-01 1.46E-01 2.60E-02 1.50E-02 4.20E-03 1.40E-02
5 4.45E-01 2.35E-01 1.12E-01 4.90E-02 9.00E-03 2.90E-02
Means 3.20E-01 1.38E-01 5.68E-02 2.65E-02 5.86E-03 1.83E-02
Std 9.49E-02 6.11E-02 4.98E-02 2.14E-02 4.04E-03 1.17E-02
Ratios 1.00E+00 4.31E-01 1.78E-01 8.29E-02 1.83E-02 5.73E-02
p-values 1.63E-04 2.53E-09 3.12E-03 1.03E-02 3.26E-04 7.66E-04
Supplementary Table 7: The number of persisters in parental strain (BW25113) to Ampicillin in complex media
after pre-incubating with antifolates. Number of persister in batch cultures pre-incubated for upto three hours in antifolates
with an starting OD600 = 0.1. Data in cfu/mL. Means and standard deviations (Std) are presented for five different experiments
(n=5). Ratios of number of persisters are listed for each time point against time zero. The p-values of T-tests for data in each time
point of the pre-incubation in either SMX or TMP versus the control in DMSO are also included. Time points in hours are 0, 1,
2, and 3.
BW25113 in complex media and Ampicillin
DMSO
0 1 2 3
1 2.58E+02 1.18E+03 9.30E+02 1.61E+03
2 3.00E+02 6.00E+02 1.50E+03 2.25E+03
3 4.00E+02 9.00E+02 9.00E+02 6.00E+02
4 3.34E+02 6.60E+02 1.35E+03 2.85E+03
5 3.40E+02 8.70E+02 1.05E+03 5.10E+02
Means 3.26E+03 8.42E+02 1.15E+03 1.56E+03
Std 5.27E+02 2.29E+02 2.66E+02 1.02E+03
Ratios 1.00E+00 2.58E+00 3.51E+00 4.79E+00
SMX
0 1 2 3
1 1.80E+02 3.00E+02 7.70E+02 4.80E+02
2 2.50E+02 1.05E+03 6.00E+02 1.20E+03
3 2.00E+02 3.30E+02 8.00E+02 5.40E+02
4 2.10E+02 6.90E+02 6.30E+02 9.00E+02
5 1.90E+02 7.50E+02 5.70E+02 9.90E+02
Means 2.06E+02 6.24E+02 6.74E+02 8.22E+02
Std 2.70E+01 3.13E+02 1.04E+02 3.06E+02
Ratios 1.00E+00 3.03E+00 3.27E+00 3.99E+00
p-values 1.89E-03 2.45E-01 6.11E-03 1.58E-01
TMP
0 1 2 3
1 4.38E+02 1.08E+02 1.00E+02 1.33E+02
2 4.00E+02 3.00E+02 3.00E+02 3.00E+02
3 3.38E+02 1.28E+02 1.25E+02 1.57E+02
4 4.30E+02 3.10E+02 3.27E+02 2.30E+02
5 3.20E+02 3.54E+02 1.43E+02 1.63E+02
Means 3.85E+02 2.40E+02 1.99E+02 1.96E+02
Std 5.36E+01 1.14E+02 1.06E+02 6.83E+01
Ratios 1.00E+00 6.23E-01 5.17E-01 5.10E-01
p-values 1.19E-01 5.23E-01 1.82E-02 6.98E-02
Supplementary Table 8:The number of persisters in parental strain (BW25113) to Ofloxacin in complex media
after pre-incubating with antifolates. Number of persister in batch cultures pre-incubated for upto three hours in antifolates
with an starting OD600 = 0.1. Data in cfu/mL. Means and standard deviations (Std) are presented for five different experiments
(n=5). Ratios of number of persisters are listed for each time point against time zero. The p-values of T-tests for data in each time
point of the pre-incubation in either SMX or TMP versus the control in DMSO are also included. Time points in hours are 0, 1,
2, and 3.
BW25113 in complex media and Ofloxacin
DMSO
0 1 2 3
1 2.96E+01 1.88E+02 3.15E+02 1.14E+03
2 2.90E+01 1.97E+02 2.76E+02 1.29E+03
3 5.73E+01 1.43E+02 2.93E+02 8.09E+02
4 4.50E+01 8.02E+01 2.44E+02 1.10E+03
5 6.60E+01 1.00E+02 2.79E+02 1.00E+03
Means 4.54E+01 1.41E+02 2.81E+02 1.07E+03
Std 1.65E+01 5.17E+01 2.61E+01 1.79E+02
Ratios 1.00E+00 3.12E+00 6.20E+00 2.35E+01
SMX
0 1 2 3
1 1.89E+02 2.04E+02 3.94E+02 2.30E+02
2 1.55E+02 2.23E+02 4.46E+02 1.87E+03
3 3.54E+01 2.74E+02 3.48E+02 1.26E+03
4 5.98E+01 1.55E+02 4.62E+02 3.80E+02
5 8.48E+01 3.52E+02 4.83E+02 8.35E+01
Means 1.05E+02 2.41E+02 4.27E+02 7.65E+02
Std 4.00E+01 7.53E+01 5.49E+01 1.50E+02
Ratios 1.00E+00 2.31E+00 4.08E+00 7.32E+00
p-values 8.25E-02 4.01E-02 6.86E-04 4.18E-01
TMP
0 1 2 3
1 3.85E+01 4.85E+01 3.90E+01 4.31E+01
2 1.04E+02 2.87E+01 4.47E+01 4.26E+01
3 6.71E+01 4.53E+01 5.44E+01 4.73E+01
4 7.56E+01 6.14E+01 4.71E+01 4.48E+01
5 5.29E+01 2.98E+01 1.17E+01 5.00E+01
Means 6.76E+01 4.28E+01 3.94E+01 4.56E+01
Std 2.46E+01 1.37E+01 1.64E+01 3.09E+00
Ratios 1.00E+00 6.33E-01 5.83E-01 6.75E-01
p-values 4.06E-01 2.44E-04 2.16E-07 3.18E-02
Supplementary Table 9: The number of persisters in parental strain (BW25113) to Ampicillin in minimal media
after pre-incubating with antifolates. Number of persister in batch cultures pre-incubated for upto three hours in antifolates
with an starting OD600 = 0.1. Data in cfu/mL. Means and standard deviations (Std) are presented for five different experiments
(n=5). Ratios of number of persisters are listed for each time point against time zero. The p-values of T-tests for data in each time
point of the pre-incubation in either SMX or TMP versus the control in DMSO are also included. Time points in hours are 0, 1,
2, and 3.
BW25113 in minimal media and Ampicillin
DMSO
0 1 2 3
1 6.25E+01 1.14E+01 1.26E+01 1.35E+01
2 4.65E+01 1.01E+01 1.10E+01 1.39E+01
3 3.16E+01 9.86E+00 7.98E+00 3.91E+00
4 3.94E+01 1.14E+01 1.77E+01 2.23E+01
5 4.32E+01 7.23E+00 1.03E+01 8.68E+00
Means 4.46E+01 1.00E+01 1.19E+01 1.25E+01
Std 1.14E+01 1.72E+00 3.62E+00 6.83E+00
Ratios 1.00E+00 2.24E-01 2.66E-01 2.79E-01
SMX
0 1 2 3
1 3.88E+01 3.68E+01 8.57E+00 3.51E+00
2 3.24E+01 2.81E+01 9.60E+00 9.21E+00
3 3.33E+01 2.01E+01 1.01E+01 4.85E+00
4 7.31E+01 1.53E+01 8.85E+00 1.65E+00
5 6.30E+01 2.47E+01 9.56E+00 1.63E+01
Means 4.81E+01 2.50E+01 9.34E+00 6.44E+00
Std 1.87E+01 8.19E+00 6.31E-01 7.00E-01
Ratios 1.00E+00 5.20E-01 1.94E-01 1.34E-01
p-values 7.34E-01 3.93E-03 1.60E-01 2.19E-01
TMP
0 1 2 3
1 7.92E+01 3.03E+01 3.90E+01 2.69E+01
2 1.13E+02 1.92E+01 1.62E+01 2.98E+01
3 1.25E+02 2.32E+01 2.34E+01 2.45E+01
4 1.07E+02 2.93E+01 2.58E+01 3.40E+01
5 1.55E+02 4.07E+01 2.68E+01 1.91E+01
Means 1.16E+02 2.85E+01 2.62E+01 2.69E+01
Std 2.77E+01 8.19E+00 8.23E+00 5.60E+00
Ratios 1.00E+00 2.46E-01 2.26E-01 2.32E-01
p-values 7.09E-04 1.12E-03 7.40E-03 6.53E-03
Supplementary Table 10: The number of persisters in parental strain (BW25113) to Ofloxacin in minimal media
after pre-incubating with antifolates. Number of persister in batch cultures pre-incubated for upto three hours in antifolates
with an starting OD600 = 0.1. Data in cfu/mL. Means and standard deviations (Std) are presented for five different experiments
(n=5). Ratios of number of persisters are listed for each time point against time zero. The p-values of T-tests for data in each time
point of the pre-incubation in either SMX or TMP versus the control in DMSO are also included. Time points in hours are 0, 1,
2, and 3.
BW25113 in minimal media and Ofloxacin
DMSO
0 1 2 3
1 1.41E+00 2.15E+00 2.37E+00 1.88E+00
2 2.40E+00 1.44E+00 1.89E+00 1.85E+00
3 2.16E+00 9.62E-01 1.33E+00 1.96E+00
4 2.22E+00 1.46E+00 1.53E+00 1.85E+00
5 2.63E+00 1.93E+00 2.59E+00 1.98E+00
Means 2.16E+00 1.59E+00 1.94E+00 1.91E+00
Std 4.62E-01 4.65E-01 5.39E-01 6.30E-02
Ratios 1.00E+00 7.34E-01 8.98E-01 8.81E-01
SMX
0 1 2 3
1 3.81E+00 1.42E+00 2.01E+00 2.01E+00
2 2.47E+00 1.72E+00 1.89E+00 2.02E+00
3 2.70E+00 1.55E+00 1.94E+00 2.00E+00
4 3.72E+00 1.83E+00 1.89E+00 2.00E+00
5 3.40E+00 1.71E+00 1.48E+00 1.99E+00
Means 3.22E+00 1.65E+00 1.84E+00 2.00E+00
Std 6.06E-01 1.61E-01 2.07E-01 1.31E-02
Ratios 1.00E+00 5.11E-01 5.71E-01 6.22E-01
p-values 1.45E-02 7.98E-01 6.97E-01 9.23E-03
TMP
0 1 2 3
1 4.78E+00 1.78E+00 1.61E+00 1.33E+00
2 1.15E+01 1.94E+00 1.52E+00 9.32E-01
3 8.25E+00 2.02E+00 1.36E+00 1.21E+00
4 6.89E+00 1.76E+00 1.67E+00 1.45E+00
5 5.41E+00 1.72E+00 1.91E+00 1.50E+00
Means 7.36E+00 1.84E+00 1.61E+00 1.28E+00
Std 2.67E+00 1.29E-01 2.02E-01 2.26E-01
Ratios 1.00E+00 2.51E-01 2.19E-01 1.75E-01
p-values 8.02E-03 7.41E-02 1.54E-01 1.02E-04
Supplementary Table 11: The number of persisters in the hyper-persister strain (∆hipA) to Ampicillin in complex
media after pre-incubating with antifolates. Number of persister in batch cultures pre-incubated for upto three hours in
antifolates with an starting OD600 = 0.1. Data in cfu/mL. Means and standard deviations (Std) are presented for five different
experiments (n=5). Ratios of number of persisters are listed for each time point against time zero. The p-values of T-tests for
data in each time point of the pre-incubation in either SMX or TMP versus the control in DMSO are also included. Time points
in hours are 0, 1, 2, and 3.
∆hipA in complex media and Ampicillin
DMSO
0 1 2 3
1 6.45E+03 6.23E+03 1.03E+04 3.11E+04
2 2.00E+03 7.50E+03 9.00E+03 5.40E+04
3 4.23E+03 6.86E+03 9.64E+03 4.25E+04
4 3.11E+03 7.18E+03 9.32E+03 4.83E+04
5 3.67E+03 7.02E+03 9.48E+03 4.54E+04
Means 3.89E+03 6.96E+03 9.54E+03 4.42E+04
Std 1.65E+03 4.73E+02 4.73E+02 8.51E+03
Ratios 1.00E+00 1.79E+00 2.45E+00 1.14E+01
SMX
0 1 2 3
1 2.70E+03 3.27E+03 1.42E+04 1.61E+04
2 2.33E+03 6.70E+03 8.63E+03 4.80E+04
3 4.00E+03 7.50E+03 1.35E+04 1.50E+05
4 3.01E+03 5.82E+03 1.21E+04 7.14E+04
5 3.11E+03 6.67E+03 1.14E+04 8.98E+04
Means 3.03E+03 5.99E+03 1.20E+04 7.50E+04
Std 6.23E+02 1.63E+03 2.16E+03 5.02E+04
Ratios 1.00E+00 1.98E+00 3.95E+00 2.48E+01
p-values 3.06E-01 2.40E-01 4.04E-02 2.13E-01
TMP
0 1 2 3
1 1.37E+03 1.90E+02 1.07E+03 1.10E+03
2 2.85E+03 7.67E+02 4.50E+02 1.63E+03
3 4.00E+03 2.00E+03 1.50E+03 1.00E+03
4 2.74E+03 9.86E+02 1.01E+03 1.24E+03
5 3.20E+03 1.25E+03 9.86E+02 1.29E+03
Means 2.83E+03 1.04E+03 1.00E+03 1.25E+03
Std 9.54E+02 6.64E+02 3.73E+02 2.38E+02
Ratios 1.00E+00 2.67E-01 2.58E-01 3.22E-01
p-values 2.49E-01 3.02E-03 2.12E-06 5.48E-06
Supplementary Table 12: The number of persisters in the hyper-persister strain (∆hipA) to Ofloxacin in complex
media after pre-incubating with antifolates. Number of persister in batch cultures pre-incubated for upto three hours in
antifolates with an starting OD600 = 0.1. Data in cfu/mL. Means and standard deviations (Std) are presented for five different
experiments (n=5). Ratios of number of persisters are listed for each time point against time zero. The p-values of T-tests for
data in each time point of the pre-incubation in either SMX or TMP versus the control in DMSO are also included. Time points
in hours are 0, 1, 2, and 3.
∆hipA in complex media and Ofloxacin
DMSO
0 1 2 3
1 8.39E+01 1.03E+02 5.58E+03 6.50E+03
2 1.22E+02 1.54E+02 6.37E+03 4.83E+03
3 1.01E+02 1.22E+02 8.34E+03 1.40E+04
4 1.31E+02 1.21E+02 1.76E+03 1.21E+04
5 8.38E+01 1.26E+02 5.21E+03 8.71E+03
Means 1.04E+02 1.25E+02 5.45E+03 9.22E+03
Std 2.15E+01 1.85E+01 2.39E+03 3.80E+03
Ratios 1.00E+00 1.20E+00 5.23E+01 8.84E+01
SMX
0 1 2 3
1 3.18E+02 2.95E+02 1.34E+03 1.50E+04
2 2.88E+02 2.87E+02 1.26E+03 1.22E+04
3 4.12E+02 4.16E+02 1.01E+03 1.72E+04
4 3.39E+02 3.39E+02 5.66E+02 8.12E+03
5 4.02E+02 3.04E+02 5.56E+02 7.16E+03
Means 3.52E+02 3.28E+02 9.47E+02 1.19E+04
Std 5.36E+01 5.29E+01 3.72E+02 4.32E+03
Ratios 1.00E+00 9.33E-01 2.69E+00 3.40E+01
p-values 1.18E-05 4.01E-05 3.17E-03 3.22E-01
TMP
0 1 2 3
1 1.54E+02 3.82E+01 1.89E+01 1.34E+01
2 7.93E+01 4.51E+01 4.35E+01 1.64E+01
3 1.21E+02 3.90E+01 2.60E+01 1.79E+01
4 4.92E+01 4.36E+01 2.76E+01 1.27E+01
5 2.00E+02 3.76E+01 1.47E+01 1.60E+01
Means 1.21E+02 4.07E+01 2.61E+01 1.53E+01
Std 5.97E+01 3.41E+00 1.10E+01 2.15E+00
Ratios 1.00E+00 3.37E-01 2.17E-01 1.27E-01
p-values 5.78E-01 8.23E-06 9.65E-04 6.32E-04
Supplementary Table 13: The number of persisters in the hyper-persister strain (∆hipA) to Ampicillin in minimal
media after pre-incubating with antifolates. Number of persister in batch cultures pre-incubated for upto three hours in
antifolates with an starting OD600 = 0.1. Data in cfu/mL. Means and standard deviations (Std) are presented for five different
experiments (n=5). Ratios of number of persisters are listed for each time point against time zero. The p-values of T-tests for
data in each time point of the pre-incubation in either SMX or TMP versus the control in DMSO are also included. Time points
in hours are 0, 1, 2, and 3.
∆hipA in minimal media and Ampicillin
DMSO
0 1 2 3
1 9.14E+02 7.80E+02 7.44E+02 7.23E+02
2 1.04E+03 7.43E+02 7.05E+02 7.45E+02
3 1.02E+03 9.79E+02 6.07E+02 5.20E+02
4 1.01E+03 1.04E+03 8.05E+02 5.65E+02
5 1.21E+03 7.24E+02 8.17E+02 8.33E+02
Means 1.04E+03 8.53E+02 7.36E+02 6.77E+02
Std 1.06E+02 1.46E+02 8.51E+01 1.31E+02
Ratios 1.00E+00 8.22E-01 7.09E-01 6.52E-01
SMX
0 1 2 3
1 1.44E+03 7.80E+02 7.77E+02 7.40E+02
2 1.75E+03 1.14E+03 8.15E+02 6.16E+02
3 1.78E+03 7.69E+02 7.67E+02 6.68E+02
4 1.16E+03 5.96E+02 7.06E+02 7.59E+02
5 1.39E+03 1.21E+03 8.39E+02 4.45E+02
Means 1.50E+03 8.98E+02 7.80E+02 6.46E+02
Std 2.63E+02 2.62E+02 5.09E+01 1.26E+02
Ratios 1.00E+00 5.97E-01 5.19E-01 4.29E-01
p-values 6.26E-03 7.48E-01 3.43E-01 7.07E-01
TMP
0 1 2 3
1 9.71E+02 3.65E+02 3.94E+02 2.68E+02
2 6.78E+02 3.82E+02 4.81E+02 2.72E+02
3 1.54E+03 4.89E+02 4.16E+02 4.79E+02
4 1.43E+03 7.00E+02 1.59E+02 3.71E+02
5 5.45E+02 7.00E+02 4.67E+02 3.81E+02
Means 1.03E+03 5.27E+02 3.84E+02 3.54E+02
Std 4.43E+02 1.65E+02 1.30E+02 8.77E+01
Ratios 1.00E+00 5.10E-01 3.71E-01 3.43E-01
p-values 9.82E-01 1.06E-02 9.79E-04 1.78E-03
Supplementary Table 14: The number of persisters in the hyper-persister strain (∆hipA) to Ofloxacin in minimal
media after pre-incubating with antifolates. Number of persister in batch cultures pre-incubated for upto three hours in
antifolates with an starting OD600 = 0.1. Data in cfu/mL. Means and standard deviations (Std) are presented for five different
experiments (n=5). Ratios of number of persisters are listed for each time point against time zero. The p-values of T-tests for
data in each time point of the pre-incubation in either SMX or TMP versus the control in DMSO are also included. Time points
in hours are 0, 1, 2, and 3.
∆hipA in minimal media and Ofloxacin
DMSO
0 1 2 3
1 1.32E+01 3.67E+01 4.43E+01 4.97E+01
2 1.27E+01 5.52E+01 6.34E+01 3.82E+01
3 1.07E+01 4.89E+01 2.87E+01 4.62E+01
4 1.23E+01 1.17E+01 4.60E+01 4.87E+01
5 1.10E+01 3.82E+01 1.99E+01 4.01E+01
Means 1.20E+01 3.81E+01 4.05E+01 4.46E+01
Std 1.10E+00 1.67E+01 1.68E+01 5.16E+00
Ratios 1.00E+00 3.18E+00 3.38E+00 3.72E+00
SMX
0 1 2 3
1 1.18E+01 8.48E+00 3.25E+00 1.97E+00
2 1.19E+01 1.21E+01 4.73E+00 2.47E+00
3 1.37E+01 1.54E+01 2.59E+00 2.07E+00
4 1.47E+01 1.18E+01 5.07E+00 2.34E+00
5 1.28E+01 1.31E+01 2.48E+00 2.29E+00
Means 1.30E+01 1.22E+01 3.62E+00 2.23E+00
Std 1.25E+00 2.50E+00 1.21E+00 2.04E-01
Ratios 1.00E+00 9.39E-01 2.80E-01 1.72E-01
p-values 2.28E-01 8.71E-03 1.22E-03 8.02E-08
TMP
0 1 2 3
1 1.60E+02 3.62E+01 2.09E+01 9.82E+00
2 1.34E+02 6.76E+01 2.64E+01 7.89E+00
3 9.09E+01 2.85E+01 6.68E+00 1.27E+01
4 1.92E+02 4.05E+01 1.71E+01 7.71E+00
5 1.20E+02 3.85E+01 2.79E+01 9.38E+00
Means 1.39E+02 4.22E+01 1.98E+01 9.51E+00
Std 3.87E+01 1.49E+01 8.53E+00 2.02E+00
Ratios 1.00E+00 3.03E-01 1.42E-01 6.82E-02
p-values 7.96E-05 6.92E-01 3.99E-02 6.04E-07
Supplementary Table 15: Ranked data for Principal Components Analysis. The six different variables were ranked as
follows: Strain (1=BW25113, 2=∆hipA), Time in hours (0,1,2,3), Antifolate (1=DMSO, 2=SMX, 3=TMP), Media (1=minimal
media, 2=complex media), Antibiotic (1=Ampicillin, 2=Ofloxacin), and Persisters (the ratio of cfu/mL at each time point in
antifolates over the cfu/mL at time zero).
Strain Time Antifolate Media Antibiotic Persisters
1 0 1 1 1 1
1 1 1 1 1 0.224
1 2 1 1 1 0.266
1 3 1 1 1 0.279
1 0 2 1 1 1
1 1 2 1 1 0.00393
1 2 2 1 1 0.16
1 3 2 1 1 0.219
1 0 3 1 1 1
1 1 3 1 1 0.246
1 2 3 1 1 0.226
1 3 3 1 1 0.232
1 0 1 1 2 1
1 1 1 1 2 0.734
1 2 1 1 2 0.898
1 3 1 1 2 0.881
1 0 2 1 2 1
1 1 2 1 2 0.511
1 2 2 1 2 0.571
1 3 2 1 2 0.622
1 0 3 1 2 1
1 1 3 1 2 0.251
1 2 3 1 2 0.219
1 3 3 1 2 0.175
2 0 1 1 1 1
2 1 1 1 1 0.822
2 2 1 1 1 0.709
2 3 1 1 1 0.652
2 0 2 1 1 1
2 1 2 1 1 0.597
2 2 2 1 1 0.519
2 3 2 1 1 0.429
2 0 3 1 1 1
2 1 3 1 1 0.51
2 2 3 1 1 0.371
2 3 3 1 1 0.343
2 0 1 1 2 1
2 1 1 1 2 3.18
2 2 1 1 2 3.38
2 3 1 1 2 3.72
2 0 2 1 2 1
2 1 2 1 2 0.939
2 2 2 1 2 0.28
2 3 2 1 2 0.172
2 0 3 1 2 1
2 1 3 1 2 0.303
2 2 3 1 2 0.142
2 3 3 1 2 0.0682
Strain Time Antifolate Media Antibiotic Persisters
1 0 1 2 1 1
1 1 1 2 1 2.58
1 2 1 2 1 3.51
1 3 1 2 1 4.79
1 0 2 2 1 1
1 1 2 2 1 3.03
1 2 2 2 1 3.27
1 3 2 2 1 3.99
1 0 3 2 1 1
1 1 3 2 1 0.623
1 2 3 2 1 0.517
1 3 3 2 1 0.51
1 0 1 2 2 1
1 1 1 2 2 3.12
1 2 1 2 2 6.2
1 3 1 2 2 2.35
1 0 2 2 2 1
1 1 2 2 2 2.31
1 2 2 2 2 4.08
1 3 2 2 2 7.32
1 0 3 2 2 1
1 1 3 2 2 0.633
1 2 3 2 2 0.583
1 3 3 2 2 0.657
2 0 1 2 1 1
2 1 1 2 1 1.79
2 2 1 2 1 2.45
2 3 1 2 1 1.14
2 0 2 2 1 1
2 1 2 2 1 1.98
2 2 2 2 1 3.95
2 3 2 2 1 2.48
2 0 3 2 1 1
2 1 3 2 1 0.267
2 2 3 2 1 0.258
2 3 3 2 1 0.322
2 0 1 2 2 1
2 1 1 2 2 1.2
2 2 1 2 2 5.23
2 3 1 2 2 8.84
2 0 2 2 2 1
2 1 2 2 2 0.933
2 2 2 2 2 2.69
2 3 2 2 2 3.4
2 0 3 2 2 1
2 1 3 2 2 0.337
2 2 3 2 2 0.217
2 3 3 2 2 0.127
Supplementary Table 16: Primers for RT-PCR
Pathway EC / TC
number
Name Enzyme LEFT RIGHT
Pteroate 3.5.4.16 folE GTP cyclohydrolase TCTGGATTACGCCAATTTCC TTCACAGGTGCTGGTCAGAG
Pteroate 3.6.1.67 nudB Dihydroneopterin triphosphate pyrophosphohydrolase GTCAGCGCACGGTAGAGTTT GAAGCGCAAGACAGAACCAT
Pteroate 4.1.2.25 folB Dihydroneopterin aldolase TGTTAGCACGCTTCAACTCG TTGCCACGCTCAATGATTAC
Pteroate 2.7.6.3 folK 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase CGCAAGATCAACCCGATTAC CTTGCTGCAATTCAATACGC
Pteroate 2.5.1.15 folP Dihydropteroate synthase TCACTGGACCTTAGCCATCC ACCGCATCTATCAGCGAGTT
Pteroate 2.5.1.54 aroF 2-dehydro-3-deoxyphosphoheptonate aldolase GAAGCCCAGATTGCTGACTC TGAATGGAACAAGGACCACA
Pteroate 2.5.1.54 aroH 2-dehydro-3-deoxyphosphoheptonate aldolase ATCGGGTAAATCACGGTCTG CGGTCACCATATCGAGGAAC
Pteroate 2.5.1.54 aroG 2-dehydro-3-deoxyphosphoheptonate aldolase GATGGATGTTTGTGCTGACG CTGATTGCCTTCCACCAGAT
Shikimate 4.2.3.4 aroB 3-dehydroquinate synthase CTGTATTCGCCGTTGTTGTG CCAAAGGTGTGTCCCAGATT
Shikimate 4.2.1.10 aroD 3-dehydroquinate dehydratase AATTCTCCGTGAGACCATGC GCAATATAAGCCTCGGTGGA
Shikimate 1.1.1.282 aroE shikimate dehydrogenase GCTCATTCATCCAGGCATTT CCATCAGCATTACGCTTTGA
Shikimate 1.1.1.25 ydiB shikimate dehydrogenase AAACGATGGTGCTGTTAGGG TCATCCCGACGGTTAAAGAG
Shikimate 2.7.1.71 aroK (aroL) shikimate kinase AACGACCATCGAAAAGCAAC AACGCTTCCAGAACTTCACG
Shikimate 2.5.1.19 aroA 3-phosphoshikimate-1-carboxyvinyltransferase TATTAATCTGCCCGGTTCCA ATCGCTATCCAGCAGATTGG
Shikimate 4.2.3.5 aroC chorismate synthase AAAGACGGTTTCCAGAGCAA TAATGCTGGAGGTCGGTTTC
pABA 2.6.1.85 pabBpabA 4-amino-4-deoxychorismate synthase GGCGCAACTACCAGAACAGT TTCCATAGCCCGTACTTTCG
pABA 4.1.3.38 pabC aminodeoxychorismate lyase GACTGGATCAGGCAGGTGTT TTCCAGAGAGGCTTGCACTT
Folate 6.3.2.12
6.3.2.17
folC dihydrofolate synthase and FPGS ATGAAAGCGCTACCGAAAAA ATCAACCACGCTTTTCAACC
Folate 1.5.1.3 folA (folM) dihydrofolate reductase CCATACCTGGGAATCAATCG ACCGACTTCACCCACGTTAC
Folate 2.1.2.1 glyA shmt GACTCACGGTTCTCCGGTTA TTTTCCAGATCGGCGTAGTC
Folate N/A gcvH gcv system GGCGATATGGTGTTTGTTGA ATGTCTGACGCCGCTTTTAC
Folate 1.4.4.2 gcvP gcv system GCTGGAGCGTAAAGATCTGG AGGTGATTGGGATCATCTCG
Folate 2.1.2.10 gcvT gcv system AAGATTTCTTCCGCCTCGTT ACGAACGGTAATTTCGATGC
Folate 1.8.1.4 lpdA gcv system TCACCAAGCGTATCAGCAAG TTGCCTTCCATCGTCACATA
Folate 1.5.1.5
3.5.4.9
folD methylenetetrahydrofolate dehydrogenase & cyclohydrolase TCTATTGATCGTTGCCGTTG ATTTTCCAGACGGTTGATGC
Folate 6.3.3.2 ygfA (fau) 5-formyltetrahydrofolate cycloligase CCTCTCTTTTGATGGCGAAC GGCACTAAAGGGATGCAAAA
Folate 1.5.1.20 metF 5-MTHFR GGCGGATTTGCTTAATCTGA CGAAAACGCAGGTAGCTTTC
Folate 2.1.1.13 metH methionine synthase ATGGATATGGGGATCGTCAA CGCGACGATTAAGAATCACA
Transport 2.A.39.1.1 codB cytosine transporter CACTCTCGGAACCGGTCTTA CGCCAATGTAACCGAGAAAT
Transport 2.A.21.2 putP proline:Na+ symporter GTGCTGTTCTCGGTGATGTG CCGAACTGTTTCCAGACGAT
Transport 2.A.3.7.1 gadC glutamic acid:4-aminobutyrate antiporter TTTATTCCCGTGGGACTTTG ATCTCGGCCCCAGAGTATTT
Transport 2.A.8.1.5 dsdX D-serine transporter GCAGATATCGGTTCGGTGAT GCAGTCGTTGACCCAGAAAT
Transport 2.A.1.40 adeQ adenine transporter GGTTGGCGTTATGTTCCTGT CAGCACGCCAACAAAGATTA
Transport 4.B.1.1.1 pnuC nicotinamide riboside transporter CGACAAACCAGTCAGAACGA TCAGACCAATCGAAACAACG
Transport 2.A.41.1.1 nupC nucleoside:H+ symporter NupC TCCATCGTTGGTGCATACAT GATCAGCGACAGCACGATAA
Transport 2.A.1.10.1 nupG nucleoside:H+ symporter NupG CGCATTCGACTTCTTCAACA ATCAGGAACATCCCTTGTGC
Transport 2.A.21.1.1 panF pantothenate:Na+ symporter CTTCCTGCAGTCTGGCTTTC GGCAAACAGCATATCGTTCA
Transport 2.A.3.1.3 aroP aromatic amino acid:H+ symporter AroP GTTCGTTAGCCGTTCTGCTC GCCACAAAGGTATCGCCTAA
Transport 2.A.14.1.2 glcA glycolate / lactate:H+ symporter AGGTACAGGCGTGATGTTCC GAACCAAACAGGGCGTTAGA
Supplementary Table 16 continuation: Primers for RT-PCR
Pathway EC / TC
number
Name Enzyme LEFT RIGHT
Transport 2.A.1.4.1 uhpT hexose-6-phosphate:phosphate antiporter ACCTACGGGTTGAGCATGAC GTCGGCGTAGTAGGAAACCA
Transport 2.A.3.1.7 cycA serine / alanine / glycine / cycloserine:H+symporter GGGCTGACGTTCTCGTGTAT GCGGAAACGGTTGTAATCAT
Transport 2.A.47.3.2 citT citrate:succinate antiporter CGGGTGATGAACTGAAAACC TCACTGCCAAATACCCACAA
Transport 2.A.1.6.6 shiA shikimate:H+ symporter GCTATAGTGGCGCTGGAGTC GTTCCCGGCAAAGTAAGTGA
Control 1.3.1.76 cysG control: Siroheme synthase TCGTCGCATCTTCTGTAACG AGAGGAGACCGCTACCATGA
Control 2.A1.27.1 hcaT control: Probable 3-phenylpropionic acid transporter GTGGTGCAAATTCTGCATTG CGCCTGTAAACGGATGACTT
Control 2.A.8.1.2 idnT control: Gnt-II system L-idonate transporter GTGGGTTTTGTCCTGCTGTT ACAGAGAGCGCTGCTACCAT
Lipogenesis 6.4.1.2 accA acetyl-CoA carboxyltransferase, subunit GGTTAGCCGTCAGGATGAGA ATCGGCGAAGATTTTACGTG
Lipogenesis 6.4.1.2 accB biotinylated biotin-carboxyl carrier protein carboxybiotin-
carboxyl-carrier protein biotin carboxyl carrier protein
AATCAGGCATCTCCGAACTG CTTGTTGCATCACAGGGAAA
Lipogenesis 6.3.4.14 accC AccC [component of biotin carboxylase] GCGTACGTTGGGAGTCTCAT CGGTTTTCACCGTAGCAAAT




fabA FabA [component of -hydroxyacyl-ACP dehy-
dratase/isomerase]
AACGGGTGGTAACTTCGACA TAACCGGATCGCCAATAAAG
Lipogenesis 2.3.1.41 fabB FabB [component of KASI] TCCGCACACTGTATCGGTAA CATTTCCCAGCACAGCTCTT
Lipogenesis 2.3.1.39,
2.3.1.86




fabF FabF [component of KASII] CGGACTGATCGAAGAAAACC CTGCCACCATGTTCACAATC




fabH FabH [component of KASIII] GGGCATTGAGAAAGACCAGA GCCCAACATGCTTTGAATCT
Lipogenesis 1.3.1.9 fabI enoyl-[acyl-carrier-protein] reductase subunit GCTGAACTGGGGAAAGTTTG CGGCGTTAACATAGTCACCA
Lipogenesis 4.2.1.59 fabZ FabZ [component of 3-hydroxy-acyl-[acyl-carrier-protein]
dehydratase]
TCAATGAGCCATTCTTCCAG AACGCCAGAATACCTGTTGC
Oxphox 1.10.3.14 cydX cytochrome d (bd-I) ubiquinol oxidase subunit X TGGATTCTGGGAACGCTTCT TCTTCTTGACCGGCTTTGC
Relative Gene expression BW25113
Page 1
0H 0H 0H 0.25H 0.25H 0.25H 0.5H 0.5H 0.5H 1H 1H 1H 2H 2H 2H
folE 9.144675 10.2175 8.07185 44.45211 66.97589 21.92833 12.720155 10.84039 14.59992 6.024225 4.78223 7.26622 0.99996 194.01193 97.505945
nudB 10.561335 12.4564 8.66627 182.47689 267.31897 97.6348 79.16679 112.77424 45.55934 42.75366 44.54839 40.95893 1.00352 27900.735 13950.869
folB 2.661545 3.34476 1.97833 7.937515 9.68894 6.18609 7.07548 6.84668 7.30428 4.81313 4.54714 5.07912 1.00201 540.11508 270.55855
folK 5.905655 10.08321 1.7281 32.286755 54.48965 10.08386 19.92579 24.89182 14.95976 10.315805 7.39293 13.23868 1.00157 560.93168 280.96663
folP 1.657095 2.47971 0.83448 10.5371 15.36613 5.70807 4.479505 5.6999 3.25911 2.136175 1.13477 3.13758 1.0006 14.72163 7.861115
aroF 30.13119 37.94379 22.31859 445.41884 723.58134 167.25633 80.02288 92.19591 67.84985 20.62809 24.24037 17.01581 1.00154 134.25875 67.630145
aroH 2.847495 4.34695 1.34804 31.021415 56.45801 5.58482 5.29174 6.09191 4.49157 1.608 2.11288 1.10312 1.0004 12.05563 6.528015
aroG 15.48088 7.60401 23.35775 10.120975 11.98808 8.25387 7.140865 1.87864 12.40309 2.019055 1.14639 2.89172 1.00087 34.24653 17.6237
aroB 12.02445 19.22162 4.82728 383.88442 653.27626 114.49258 61.021925 72.24937 49.79448 22.68587 23.57503 21.79671 1.00256 989.98742 495.49499
aroD 0.51624 0.39951 0.63297 0.18429 0.08319 0.28539 0.17202 0.04141 0.30263 0.129625 0.04051 0.21874 0.99862 0.01839 0.508505
aroE 25.57353 34.27954 16.86752 109.47944 172.47998 46.47889 52.292855 54.21134 50.37437 18.006845 17.99536 18.01833 1.00274 2979.8545 1490.4286
ydiB 0.479545 0.38448 0.57461 0.12216 0.01434 0.22998 0.08769 0.00357 0.17181 0.01069 0.00151 0.01987 0.99792 0.00006 0.49899
aroK(aroL) 91.163545 135.86932 46.45777 4190.7002 7368.2562 1013.1442 733.09986 1047.1859 419.01378 207.22044 366.05146 48.38941 1.00424 161758.94 80879.974
aroA 7.5285 11.80355 3.25345 9.04038 14.93966 3.1411 3.01088 3.30273 2.71903 2.652345 1.81881 3.48588 1.00103 15.2027 8.101865
aroC 2.42583 3.38421 1.46745 17.08819 27.93392 6.24246 6.49109 6.88303 6.09915 4.61915 4.65421 4.58409 1.00072 62.61945 31.810085
pabBpabA 1.426235 1.83481 1.01766 3.04126 4.35 1.73252 1.112055 0.74175 1.48236 0.50403 0.49097 0.51709 1.00001 1.73056 1.365285
pabC 4.42432 6.21253 2.63611 85.07338 154.91945 15.22731 7.653155 7.34199 7.96432 2.62361 2.43352 2.8137 1.00095 102.08047 51.54071
folC 1.63338 1.77785 1.48891 20.27686 30.12042 10.4333 5.77724 3.58925 7.96523 2.364265 2.49021 2.23832 1.00016 15.61466 8.30741
folA(folM) 5.615435 7.94487 3.286 35.65792 55.62122 15.69462 27.995965 33.91267 22.07926 8.391675 10.95998 5.82337 1.00178 414.61962 207.8107
glyA 14.838485 21.67411 8.00286 34.57464 60.7217 8.42758 24.53242 38.62525 10.43959 14.650415 25.95596 3.34487 1.00199 5341.4005 2671.2012
gcvH 3.16662 3.40263 2.93061 1.12738 1.05555 1.19921 0.44108 0.34727 0.53489 0.61118 0.18044 1.04192 1.00037 2.60841 1.80439
gcvP 1.116535 1.14466 1.08841 0.3385 0.18545 0.49155 0.16774 0.09668 0.2388 0.33564 0.04673 0.62455 0.99929 0.0901 0.544695
gcvT 1.97759 2.16201 1.79317 0.881345 0.65161 1.11108 0.391435 0.308 0.47487 0.259555 0.11847 0.40064 0.99972 0.38943 0.694575
lpdA 21.726115 20.02349 23.42874 27125.794 51367.628 2883.9602 4532.562 7085.4194 1979.7047 1086.4594 2077.794 95.12476 1.00295 66388.326 33194.665
folD 12.647805 13.12487 12.17074 85.208535 154.19467 16.2224 32.89442 54.14695 11.64189 25.302165 26.87719 23.72714 1.00174 6966.8381 3483.9199
ygfA(fau) 57.95739 63.53668 52.3781 1219.0797 2277.2254 160.93407 229.24736 296.22766 162.26705 60.91292 120.49573 1.33011 1.00332 10485.983 5243.4932
metF 0.765685 0.81718 0.71419 2.69431 2.76269 2.62593 1.073305 0.91674 1.22987 0.488115 0.60774 0.36849 1.00044 3.78082 2.39063
metH 0.382925 0.48166 0.28419 0.516965 0.31747 0.71646 0.297145 0.09327 0.50102 0.366125 0.07865 0.6536 0.9993 0.16205 0.580675
codB N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
putP 3.37969 3.58209 3.17729 40.269805 62.70533 17.83428 6.714855 8.72817 4.70154 2.07238 3.34642 0.79834 1.00099 59.11982 30.060405
gadC 45.064885 72.57586 17.55391 0.0069 0.00303 0.01077 0.049345 0.00775 0.09094 0.000735 0.00006 0.00141 0.10442 0.00055 0.052485
dsdX 0.54957 0.46704 0.6321 0.01518 0.0011 0.02926 0.10493 0.00784 0.20202 0.004675 0.00013 0.00922 0.31167 0.00192 0.156795
adeQ 0.859715 0.46293 1.2565 0.239045 0.00382 0.47427 0.39079 0.02526 0.75632 0.004685 0.00076 0.00861 2.00766 0.01454 1.0111
pnuC 2.511905 0.73027 4.29354 0.124195 0.05193 0.19646 0.31194 0.09393 0.52995 0.009515 0.0179 0.00113 0.42715 0.05663 0.24189
nupC 1.185085 1.04861 1.32156 0.32361 0.32118 0.32604 0.741955 0.61524 0.86867 1.56146 0.71057 2.41235 1.88578 1.00788 1.44683
nupG 1.057635 0.85118 1.26409 0.21522 0.09566 0.33478 0.162275 0.15658 0.16797 0.038595 0.03719 0.04 1.38709 0.20482 0.795955
panF 1.63384 1.1793 2.08838 37.287555 38.71557 35.85954 4.32776 6.91999 1.73553 12.12324 22.10677 2.13971 11.74694 44.33946 28.0432
aroP 1.27593 1.05755 1.49431 1.58138 1.96095 1.20181 2.1983 1.79501 2.60159 1.52608 2.88066 0.1715 1.09334 3.72996 2.41165
glcA 0.69173 0.49562 0.88784 0.052805 0.0043 0.10131 0.222985 0.03658 0.40939 0.00204 0.00299 0.00109 0.45959 0.03834 0.248965
uhpT 0.412055 0.27857 0.54554 0.221195 0.02561 0.41678 0.38966 0.03445 0.74487 0.00437 0.00053 0.00821 0.50884 0.00804 0.25844
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cycA 2.85968 3.19984 2.51952 6.63327 8.6292 4.63734 5.70624 4.50641 6.90607 25.5129 49.23326 1.79254 5.6855 69.15694 37.42122
citT 0.85046 0.45153 1.24939 0.06892 0.0038 0.13404 0.092645 0.02371 0.16158 0.001645 0.00066 0.00263 0.32419 0.0101 0.167145
shiA 4.649155 4.0415 5.25681 2.807625 2.92234 2.69291 1.94618 1.33506 2.5573 2.1402 3.86584 0.41456 1.97207 17.57073 9.7714
cysG N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
hcaT N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
idnT N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
accA 10.0124 12.08004 7.94476 982.10499 1574.3515 389.85852 86.50489 88.37858 84.6312 4073.6034 8117.5061 29.70071 105.55337 6766.6534 3436.1034
accB 45.66983 74.48682 16.85284 57736.375 100121.83 15350.924 812.82187 1069.5765 556.0672 289622.98 578845.89 400.06816 213.32127 26442.569 13327.945
accC 2.266245 2.5161 2.01639 41.66124 40.78021 42.54227 12.28659 11.1305 13.44268 202.85683 398.60796 7.1057 65.10072 565.10525 315.10299
accD 6.580245 7.92599 5.2345 100.91522 170.25429 31.57615 15.67808 13.75495 17.60121 269.99764 535.70169 4.29358 49.69134 548.89036 299.29085
fabA 39.484275 58.86887 20.09968 41805.414 79546.09 4064.7374 139.41276 274.77044 4.05508 127812.27 255488.33 136.21203 352.36456 83812.908 42082.636
fabB 95.34278 123.58783 67.09773 43781.613 83831.382 3731.843 427.21287 634.53901 219.88672 293563.59 586611.92 515.26142 512.95259 62673.164 31593.058
fabD 15.95555 21.10149 10.80961 77696.413 121895.75 33497.079 258.45737 343.36174 173.553 55092.799 109873.91 311.69042 233.03536 27724.305 13978.67
fabF 37.763935 44.82802 30.69985 104417.64 197330.15 11505.13 411.112 504.57115 317.65285 279483.5 558792.88 174.11001 1012.7016 150945.93 75979.318
fabG 24.10711 23.33933 24.87489 31742.791 41057.882 22427.701 220.35078 162.81252 277.88904 17843.55 35264.229 422.87028 612.38422 34511.403 17561.893
fabH 28.486775 43.48839 13.48516 99381.002 167045.09 31716.912 330.62279 455.58608 205.65949 77685.366 155002.48 368.24776 408.29808 61022.411 30715.355
fabI 4.75549 4.98005 4.53093 140.4132 236.13215 44.69424 20.57086 27.64567 13.49605 1260.0911 2492.6234 27.55873 46.5709 1954.9614 1000.7662
fabZ 24.890935 27.04936 22.73251 7596.91 7193.8199 8000 168.3529 227.51753 109.18827 13424.148 26744.228 104.06898 198.24245 58603.92 29401.081
cydX 111.00395 142.99655 79.01134 1298.0944 365.60936 2230.5795 26.30256 21.2478 31.35732 910.00231 1743.8004 76.20426 30.43703 3163.123 1596.78
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3H 3H 3H pvals_0H pvals_0.5H pvals_1H pvals_2H pvals_3H
0.644905 0.7 0.58981 5.73E-04 7.91E-03 8.47E-04 1.98E-03 2.25E-02 7.93E-04
58125.457 116249.76 1.15683 1.28E-03 6.58E-03 5.65E-03 6.15E-05 2.25E-02 2.25E-02
3831.4076 7662.0492 0.76594 5.20E-03 2.06E-03 4.72E-05 1.62E-04 2.25E-02 2.25E-02
647.46134 1294.2696 0.65306 1.79E-02 1.35E-02 2.22E-03 3.13E-03 2.25E-02 2.26E-02
1548.5733 3096.0755 1.07116 3.01E-02 7.59E-03 3.86E-03 1.88E-02 2.25E-02 2.25E-02
829.20752 1657.9266 0.48841 2.31E-03 1.10E-02 7.82E-04 1.11E-03 2.25E-02 2.26E-02
91.33542 181.90287 0.76797 1.66E-02 1.78E-02 1.14E-03 1.72E-02 2.25E-02 2.26E-02
16700.509 33399.429 1.58843 8.61E-03 1.37E-03 1.81E-02 1.80E-02 2.25E-02 2.25E-02
6892.7985 13782.965 2.63205 1.18E-02 1.33E-02 1.15E-03 5.60E-05 2.25E-02 2.25E-02
0.862045 1.50689 0.2172 1.89E-03 5.08E-04 8.19E-04 3.48E-04 2.25E-02 7.47E-02
105298.83 210597.13 0.53444 3.94E-03 9.64E-03 4.66E-05 1.52E-08 2.25E-02 2.25E-02
0.00233 0.00356 0.00466 1.09E-03 4.99E-04 2.82E-04 2.87E-06 2.24E-02 1.82E-07
110861.24 221720.96 1.51701 7.31E-03 1.50E-02 5.62E-03 1.53E-02 2.25E-02 2.25E-02
126.56341 253.06694 0.05987 1.18E-02 1.42E-02 6.95E-04 7.54E-03 2.25E-02 2.28E-02
500.32099 999.5737 1.06828 1.23E-02 1.24E-02 1.69E-04 3.13E-06 2.25E-02 2.25E-02
1.86796 3.64786 0.08806 2.13E-02 1.14E-02 6.52E-02 2.31E-05 2.25E-02 4.87E-02
243.51476 485.92931 1.1002 8.01E-03 1.72E-02 7.28E-05 4.54E-04 2.25E-02 2.25E-02
5.701895 11.22698 0.17681 1.69E-03 7.70E-03 6.34E-03 2.83E-04 2.25E-02 2.78E-02
10055.249 20109.726 0.77185 7.54E-03 9.51E-03 1.56E-03 3.80E-03 2.25E-02 2.25E-02
2087967.1 4175933.4 0.85092 7.26E-03 1.56E-02 1.02E-02 1.72E-02 2.25E-02 2.25E-02
148029.97 296058.04 1.90452 3.93E-04 9.17E-03 9.26E-04 2.58E-02 2.25E-02 2.25E-02
309.73035 619.36109 0.09961 1.89E-03 1.74E-03 2.42E-04 5.76E-03 2.25E-02 2.26E-02
4.155815 8.14302 0.16861 1.17E-03 4.65E-02 6.21E-04 1.19E-03 2.25E-02 3.04E-02
212678.22 425351.88 4.57198 2.24E-04 1.92E-02 9.15E-03 1.98E-02 2.25E-02 2.25E-02
9707.5345 19414.995 0.07391 5.59E-05 1.69E-02 1.22E-02 1.40E-04 2.25E-02 2.25E-02
0.434315 0.46863 0.4 3.18E-04 1.84E-02 2.75E-03 2.24E-02 2.25E-02 1.22E-04
29.204865 58.39912 0.01061 1.57E-03 5.42E-05 5.03E-02 1.77E-03 2.25E-02 2.36E-02
31.829795 63.34087 0.31872 8.43E-04 5.24E-03 2.69E-03 6.22E-03 2.25E-02 2.32E-02
N/A N/A N/A N/A N/A N/A N/A N/A N/A
98.541245 196.02257 1.05992 2.40E-04 9.38E-03 3.90E-03 2.82E-02 2.25E-02 2.25E-02
77628.345 63459.108 91797.581 1.09E-02 5.06E-07 6.38E-05 1.52E-08 1.00E-04 1.09E-03
21.196285 0.02262 42.36995 1.10E-03 6.81E-06 3.90E-04 6.95E-07 1.11E-03 2.40E-02
0.00095 0.00187 0.00003 6.03E-02 3.04E-03 1.02E-02 5.18E-07 9.86E-02 2.83E-08
1.39358 0.13683 2.65033 2.79E-02 2.26E-04 3.19E-03 2.39E-06 1.93E-03 6.42E-02
255.47057 1.60978 509.33136 1.43E-02 4.30E-07 7.18E-03 3.71E-02 2.20E-02 2.25E-02
58.11854 0.22761 116.00947 6.76E-02 7.65E-04 1.54E-06 7.12E-08 6.11E-02 2.30E-02
1547.4709 26.80242 3068.1394 1.37E-02 5.16E-05 1.56E-02 1.93E-02 1.03E-02 2.20E-02
306.37218 1.50454 611.23981 1.60E-02 1.18E-02 3.57E-03 5.70E-02 2.05E-02 2.25E-02
46.726275 0.04614 93.40641 1.13E-02 8.73E-05 1.86E-03 3.02E-08 2.52E-03 2.32E-02
175.01311 0.00005 350.02616 1.68E-03 2.04E-03 9.68E-03 4.96E-07 3.60E-03 2.27E-02
pvals_0.25
H
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176.42849 54.00019 298.85678 1.10E-03 3.94E-03 2.10E-03 2.15E-02 1.85E-02 1.31E-02
29.76715 0.28337 59.25093 5.83E-02 1.63E-04 1.92E-04 3.24E-08 1.16E-03 2.33E-02
75.886755 66.16221 85.6113 9.12E-04 1.34E-04 1.15E-02 3.71E-02 1.91E-02 5.57E-04
N/A N/A N/A N/A N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A N/A N/A N/A N/A
155548.58 311053.98 43.17622 1.71E-03 1.03E-02 1.60E-05 2.23E-02 2.16E-02 2.25E-02
13548.683 17494.631 9602.734 1.15E-02 1.42E-02 3.18E-03 2.25E-02 2.20E-02 2.71E-03
2193.092 262.31816 4123.8658 1.27E-03 1.56E-05 3.48E-04 2.16E-02 1.62E-02 1.88E-02
9525.9719 18158.248 893.69593 1.88E-03 1.30E-02 5.67E-04 2.22E-02 1.74E-02 1.96E-02
34517.116 66172.044 2862.1876 7.52E-03 1.95E-02 2.19E-02 2.25E-02 2.23E-02 2.00E-02
22842.983 34529.064 11156.902 2.86E-03 1.99E-02 7.06E-03 2.25E-02 2.20E-02 7.73E-03
14688.096 26275.758 3100.4342 3.73E-03 9.31E-03 3.44E-03 2.24E-02 2.20E-02 1.59E-02
5058994.6 10117947 41.68789 1.21E-03 1.91E-02 1.69E-03 2.25E-02 2.21E-02 2.25E-02
72418.804 144829.15 8.46126 3.68E-05 2.75E-03 2.22E-03 2.18E-02 2.15E-02 2.25E-02
48430.465 96860.93 0.0003 8.66E-03 1.26E-02 4.47E-03 2.24E-02 2.21E-02 2.25E-02
71192.781 135728.96 6656.599 1.19E-04 1.28E-02 4.09E-03 2.19E-02 2.11E-02 1.96E-02
14633.818 27267.636 2000 2.71E-04 9.37E-05 3.92E-03 2.23E-02 2.23E-02 1.83E-02
280.00028 557.59119 2.40937 2.71E-03 1.38E-02 1.30E-03 2.00E-02 2.20E-02 2.24E-02
Relative Gene expression JW15110 versus BW25113
0H 0H 0H 0.25H 0.25H 0.25H 0.5H 0.5H 0.5H 1H 1H 1H 2H
folE 0.14632 0.90884 0.1224 0.00494 0.36326 1.9258 7.68537 0.56843 0.19936 1.0016 1.22297 0.53169 0.99543
nudB 0.05765 1.96608 0.09902 0.00021 0.62786 2.19147 0.28923 0.18772 0.066 1.00118 0.44726 0.10692 0.99518
folB 0.20386 0.87335 0.56355 0.0241 0.55121 2.37991 0.59231 0.59695 0.40422 1.00093 1.60455 0.7562 0.99883
folK 0.28353 0.54758 0.69529 0.0141 0.14268 3.13777 0.07191 0.15901 0.05357 0.99982 0.62906 0.33234 0.99902
folP 1.78267 0.72024 0.71763 0.03757 0.11668 0.60566 0.08037 0.19067 0.17958 1.00001 1.06053 0.31489 1.00053
aroF 0.24155 0.97845 0.08434 0.00131 0.07399 1.72439 0.24766 0.11636 0.05048 1.0002 0.21678 0.07226 0.99941
aroH 0.01519 0.41458 0.53553 1.76182 0.20052 1.76182 0.22772 0.34676 0.2542 1.00052 0.64733 0.20437 0.99831
aroG 0.3506 1.17782 0.07254 1.76182 0.13289 1.59301 0.36571 0.31579 0.09169 0.99916 1.05576 0.15287 0.99955
aroB 0.36948 1.27783 0.24314 0.00614 0.14006 1.79974 0.07759 0.28175 0.25357 1.00104 1.13994 0.50119 0.99935
aroD 1.85727 0.8489 0.91902 0.40386 0.64361 0.25173 0.77602 0.65246 0.08542 0.99981 0.9024 0.19326 0.99762
aroE 0.27344 0.76625 0.09328 0.0039 0.16402 0.74232 0.27242 0.27218 0.01665 1.00085 0.96009 0.28603 0.99728
ydiB 1.288 0.77947 1.25441 5.04717 1.967 0.05623 0.21645 1.21978 0.02898 0.99898 1.82805 0.10213 0.99359
aroK (aroL) 0.20914 0.83175 0.06948 0.00071 0.15851 1.91415 0.04283 0.35483 0.01066 1.00172 0.91399 0.41149 0.99657
aroA 0.85801 0.79911 0.26778 0.1027 0.32639 1.68728 0.2695 0.53198 0.11172 1.00046 1.14667 0.12691 0.99538
aroC 0.1009 0.61973 0.53468 0.00846 0.33945 1.82559 0.06391 0.34701 0.47882 1.00066 0.79921 0.06246 0.99793
pabBpabA 0.50701 0.62702 0.63307 0.0479 0.24261 0.88841 0.28482 0.43448 0.00467 0.9998 0.45925 0.27786 0.99688
pabC 0.09465 0.58145 0.28317 0.00444 0.15282 1.52738 6.21128 0.31787 0.01799 1.00054 0.77685 0.23543 0.99918
folC 0.13567 0.77883 0.7969 0.02309 0.14945 1.28931 0.28811 0.34431 0.16041 1.00067 0.99725 1.23855 0.99449
folA (folM) 0.17114 0.80316 0.35375 0.02292 0.45156 2.72397 0.84059 0.38153 0.48853 1.00108 1.75606 0.39368 0.99891
glyA 0.2035 1.17909 0.09657 0.02159 0.6372 5.17866 0.08589 0.35799 0.4903 1.00087 1.24387 0.23691 0.99939
gcvH 2.277 1.26065 0.63632 1.66384 0.60448 1.50771 1.26345 1.63595 3.03325 0.99902 3.8235 0.10806 1.00059
gcvP 2.2144 2.12724 0.05004 1.7819 0.77474 1.36355 1.79927 2.01926 1.88223 0.99956 5.41922 0.27685 1.00037
gcvT 1.63 1.18217 0.78088 0.61123 0.41487 0.83574 2.99578 0.72149 1.67908 0.99923 1.76056 0.50509 0.99531
lpdA 0.00201 2.81391 0.06992 0.00001 0.2944 5.48435 0.12764 0.36708 0.18405 1.00175 0.76857 2.32597 0.99855
folD 0.06341 0.74131 0.10606 0.00163 0.2232 3.55849 0.49638 0.14529 0.37402 1.00078 0.39871 0.22032 0.99902
ygfA (fau) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
metF 0.24979 1.16021 0.90677 0.00312 0.16895 0.36441 0.80945 0.26602 0.36817 0.7 0.64717 1.7142 1.00125
metH 1.08216 0.90153 0.66949 0.06268 0.51436 0.3097 0.99287 0.6907 0.49779 0.9991 1.02466 0.1986 1.00101
codB N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
putP 0.19664 0.89072 0.84888 0.04234 0.14429 1.53935 2.25068 0.37096 1.26028 1.00047 1.44371 3.80635 0.99916
gadC 3.128 3.22655 0.07321 10 9.03392 0.02985 1.00015 6.24556 1.84242 0.99903 1.33903 0.59804 9.3352
dsdX 0.00017 1.04792 2.0446 11.70165 7.53659 0.03806 0.9998 2.57479 1.64486 0.99938 1.86484 0.10342 17.20828
adeQ 0.04036 1.53758 1.68375 15 15.96469 0.02287 1.00025 2.80437 1.95705 0.9999 3.3114 1.73312 5.69441
pnuC 0.05744 0.9218 0.46861 9.42092 0.89929 0.34928 1.00084 1.42067 4.33224 0.99933 0.56045 16.81245 0.00155
nupC 0.06399 0.88498 0.82266 3.27273 2.31798 1.43903 1.00003 1.24636 11.06143 1.0003 0.875 0.28726 7.52772
nupG 0.00674 1.01031 1.3884 9.69545 0.7924 0.11968 1.00026 1.95349 14.66983 0.99931 1.30372 1.30372 3.12268
panF 0.04409 1.38677 0.99636 0.10948 0.24142 0.18018 0.99984 0.55511 26.86518 1.00017 0.76469 1.05381 4.51549
aroP 0.13563 1.68538 1.26726 0.52426 1.28474 0.56857 1.00017 1.04218 4.82021 0.99991 0.40678 2.1284 23.60469
glcA 1.351 0.72718 1.56657 10 1.28288 0.01441 1.00041 1.75049 1.29854 0.99944 0.56352 5.36848 50.0055
uhpT 2.6273 1.22438 1.92491 5.59976 1.13242 0.06831 1.00007 1.33932 1.79802 0.99933 0.94041 1.07217 54.72637
cycA 1.9213 0.51445 0.5499 0.53099 0.36377 0.13826 0.99989 0.83374 4.64 1.00028 0.23059 1.57146 10.51957
citT 2.081 1.16871 1.72283 5 4.08565 0.02432 1.00002 1.78453 2.75561 0.99927 0.73989 0.33427 23.84274
shiA 1.11552 0.52138 0.39259 4.57836 0.99946 0.78259 1.00075 1.66036 7.1843 0.99985 0.2664 0.79694 6.91846
cysG N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
hcaT N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
idnT N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
accA 0.01576 0.68039 0.17965 0.02123 0.54929 4.85808 0.99931 0.60008 4.5988 1.00105 0.30021 1.14098 0.65937
accB 0.03451 0.2236 0.12364 0.00997 0.13531 0.45743 0.99974 0.70142 6.84054 1.00114 0.14231 2.10903 0.09154
accC 0.567 0.55043 0.60361 0.07793 0.19694 0.4676 1.00026 0.99389 6.05235 1.00043 0.13821 2.37588 1.69356
accD 0.1217 0.78125 0.28224 0.06758 1.41635 4.97299 0.99963 1.08743 7.32889 1.00135 0.92722 4.28456 1.15658
fabA 0.03711 1.03788 0.13834 0.00973 0.55278 12.76088 1.00037 0.86519 258.02484 1.00137 0.08606 1.16439 0.09533
fabB 0.48018 0.64837 0.07634 0.10492 0.37682 2.29279 0.99936 0.57606 5.73602 1.00122 0.2491 0.62894 0.48786
fabD 0.09721 2.00112 0.20625 0.02296 0.49174 12.56957 0.99951 1.30066 17.03982 1.00111 0.46541 2.26626 0.07615
fabF 0.03036 0.95797 0.11564 0.00163 0.83471 5.51029 0.99983 1.12083 8.20285 1.0013 0.1098 1.96576 0.69409
fabG 0.05664 1.25197 0.10763 0.01696 0.54273 4.82859 1.0002 1.61445 10.18525 1.0016 0.48638 1.45574 0.17101
fabH 0.05258 1.29782 0.17304 0.01477 0.25406 3.27314 0.99934 45 23.88507 1.00142 0.06521 2.42419 0.19576
fabI 0.02587 0.63883 0.28702 0.01208 0.5006 0.5006 1.00041 0.54928 17.67543 1.00147 0.06207 1.03673 0.00561
fabZ 0.05237 1.27282 0.11549 0.0053 0.45386 0 0.99997 0.59627 7.38775 1.00131 0.23314 1.97624 0.02
cydX 1.31 0.89221 0.06672 1.53504 18.59683 3.31356 1.00081 1.9535 7.29511 1.00158 2.82258 0.79488 2.1329
Relative Gene expression JW15110 versus BW25113
2H 2H 3H 3H 3H pvals_0H pvals_0.25H pvals_0.5H pvals_1H pvals_2H pvals_3H
0.01058 1.00462 0.00002 0.000246 0.000133 1.43E-02 7.28E-02 5.33E-02 7.29E-02 4.23E-02 4.26E-10
0.01088 0.99941 0.00029 0.003567 0.0019285 6.88E-02 9.35E-02 6.15E-04 2.06E-02 4.19E-02 8.98E-08
0.10938 0.9994 0.0117 0.14391 0.077805 1.44E-02 9.85E-02 1.78E-03 6.80E-02 4.22E-02 1.71E-04
0.02316 0.99905 0.00078 0.009594 0.005187 5.52E-03 9.32E-02 1.29E-04 2.15E-02 4.22E-02 6.54E-07
0.05565 0.99888 0.00039 0.004797 0.0025935 8.55E-02 5.22E-03 1.70E-04 4.76E-02 4.22E-02 1.63E-07
0.03813 0.99961 0.00018 0.002214 0.001197 1.77E-02 5.51E-02 4.49E-04 1.86E-02 4.22E-02 3.46E-08
0.02151 0.99839 0.00148 0.018204 0.009842 4.98E-03 6.88E-02 2.48E-04 2.39E-02 4.21E-02 2.38E-06
0.00203 0.99809 0.00009 0.001107 0.0005985 2.95E-02 7.83E-02 1.26E-03 4.61E-02 4.21E-02 8.63E-09
0.18859 0.99985 0.04613 0.567399 0.3067645 3.74E-02 6.04E-02 6.38E-04 6.01E-02 4.22E-02 4.40E-03
0.00931 0.99903 0.0128 0.15744 0.08512 5.87E-02 3.82E-03 1.45E-02 3.57E-02 4.21E-02 2.08E-04
0.02695 1.00351 0.00009 0.001107 0.0005985 9.05E-03 8.99E-03 1.08E-03 3.92E-02 4.23E-02 8.63E-09
0.00773 1.00728 0.003 0.0369 0.01995 5.81E-02 4.49E-02 3.01E-02 9.67E-02 4.23E-02 9.97E-06
0.18493 1.00318 0.0305 0.37515 0.202825 1.15E-02 6.64E-02 1.58E-03 3.47E-02 4.22E-02 1.52E-03
0.04444 0.99897 0.00018 0.002214 0.001197 1.96E-02 6.12E-02 2.97E-03 5.27E-02 4.19E-02 3.46E-08
0.0575 1.00093 0.00248 0.030504 0.016492 6.86E-03 6.71E-02 2.90E-03 3.15E-02 4.22E-02 6.77E-06
0.00855 0.99829 0.00013 0.001599 0.0008645 9.83E-04 1.39E-02 2.65E-03 1.92E-02 4.20E-02 1.80E-08
0.0165 0.99955 0.00388 0.047724 0.025802 4.08E-03 4.61E-02 6.17E-02 2.84E-02 4.22E-02 1.69E-05
0.05596 1.00398 0.00314 0.038622 0.020881 1.87E-02 3.31E-02 5.42E-04 4.28E-02 4.22E-02 1.09E-05
0.23367 0.99796 0.04816 0.592368 0.320264 9.73E-03 9.44E-02 9.02E-03 9.10E-02 4.20E-02 4.95E-03
0.05236 0.99867 0.00197 0.024231 0.0131005 2.79E-02 6.20E-02 2.86E-03 6.26E-02 4.21E-02 4.24E-06
0.01233 0.99802 0.00056 0.006888 0.003724 4.99E-02 5.15E-02 2.11E-02 6.24E-02 4.22E-02 3.36E-07
0.01984 0.99909 0.00071 0.008733 0.0047215 5.79E-02 4.04E-02 5.04E-04 5.24E-02 4.22E-02 5.42E-07
0.01015 0.99903 0.00029 0.003567 0.0019285 5.05E-02 8.92E-03 3.49E-02 8.31E-02 4.19E-02 8.98E-08
0.08632 0.99957 0.00461 0.056703 0.0306565 9.71E-02 6.55E-02 8.61E-04 5.30E-02 4.21E-02 2.41E-05
0.05601 0.99843 0.0492 0.60516 0.32718 8.64E-03 8.42E-02 2.34E-03 1.91E-02 4.21E-02 5.25E-03
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
0.01933 0.99998 0.01385 0.170355 0.0921025 4.90E-02 1.58E-03 8.96E-03 9.58E-02 4.23E-02 2.47E-04
0.01387 0.99933 0.0007 0.00861 0.004655 4.35E-02 3.27E-03 1.99E-02 4.40E-02 4.23E-02 5.26E-07
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
0.02417 0.99885 0.00781 0.096063 0.0519365 2.55E-02 4.72E-02 6.42E-02 3.39E-02 4.21E-02 7.21E-05
0.08074 0.03095 0.00195 0.023985 0.0129675 3.85E-02 2.34E-02 3.38E-02 9.30E-02 5.59E-02 4.15E-06
0.03921 1.05524 0.08753 1.076619 0.5820745 9.63E-02 2.53E-02 2.47E-02 9.85E-02 4.56E-02 2.81E-02
0.08048 15.41122 0.01594 0.196062 0.106001 8.83E-02 2.12E-02 2.19E-02 2.75E-02 3.09E-02 3.37E-04
0.04597 0.05 0.00513 0.063099 0.0341145 1.74E-02 4.76E-02 3.55E-02 4.39E-02 2.57E-05 3.00E-05
0.10572 0.23659 1.64535 18.42792 10.036635 2.61E-02 1.27E-02 4.09E-02 3.32E-02 5.76E-02 2.03E-02
0.08397 4.42467 0.45997 5.657631 3.0588005 6.78E-02 4.98E-02 3.84E-02 1.84E-02 3.53E-02 3.04E-02
0.13032 0.92683 0.79335 9.758205 5.2757775 6.79E-02 2.14E-04 4.33E-02 5.66E-02 5.90E-02 2.40E-02
0.15652 0.357 0.55935 6.880005 3.7196775 9.55E-02 4.88E-02 4.16E-02 7.58E-02 4.61E-02 2.75E-02
0.04292 0.0977 0.17445 2.145735 1.1600925 4.83E-02 4.71E-02 2.50E-02 4.83E-02 4.45E-02 8.05E-02
0.01394 0.4518 0.37573 4.621479 2.4986045 1.50E-02 5.33E-02 2.43E-02 9.27E-02 4.39E-02 3.46E-02
0.07748 1.12861 0.96991 11.929893 6.4499015 9.93E-02 2.88E-03 4.50E-02 8.81E-02 4.73E-02 2.27E-02
0.04685 0.03475 0.15981 1.965663 1.0627365 1.32E-02 3.14E-02 2.37E-02 2.52E-02 4.72E-02 9.15E-02
0.04416 0.10106 0.05207 0.640461 0.3462655 2.83E-02 4.59E-02 3.65E-02 2.89E-02 6.13E-02 6.14E-03
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
0.126 0.27547 0.09705 1.193715 0.6453825 7.13E-03 6.50E-02 4.90E-02 5.49E-02 5.54E-03 3.79E-02
0.10335 33.744 0.15255 1.876365 1.0144575 3.89E-04 2.67E-03 4.53E-02 8.96E-02 4.55E-02 9.79E-02
0.05672 0.43305 0.50175 6.171525 3.3366375 1.36E-04 2.27E-03 4.23E-02 8.17E-02 6.38E-02 2.90E-02
0.11242 0.27551 0.19854 2.442042 1.320291 9.30E-03 5.13E-02 4.15E-02 4.35E-02 2.73E-02 6.70E-02
0.10226 2.87841 0.47496 5.842008 3.158484 2.02E-02 4.95E-02 4.23E-02 5.35E-02 9.81E-02 2.98E-02
0.09391 0.27397 0.39406 4.846938 2.620499 7.19E-03 9.23E-02 4.77E-02 2.27E-02 2.45E-03 3.35E-02
0.08554 1.90755 0.1677 2.06271 1.115205 7.43E-02 4.99E-02 4.12E-02 6.92E-02 6.61E-02 8.53E-02
0.07336 0.23611 0.23145 2.846835 1.5391425 1.66E-02 5.82E-02 4.13E-02 9.66E-02 6.99E-03 5.49E-02
0.05689 0.72235 0.42557 5.234511 2.8300405 3.09E-02 6.53E-02 3.85E-02 9.53E-02 7.98E-03 3.18E-02
0.0548 1.52658 0.38494 4.734762 2.559851 3.40E-02 8.79E-02 2.21E-02 8.34E-02 4.76E-02 3.40E-02
0.16405 0.25401 0.015 0.1845 0.09975 6.15E-03 5.55E-03 4.38E-02 4.47E-02 7.07E-04 2.94E-04
0.02012 0.02 1.33806 16.458138 8.898099 3.20E-02 3.01E-03 4.60E-02 9.02E-02 1.67E-10 2.12E-02
0.05605 1.48165 0.17794 2.188662 1.183301 5.73E-02 3.35E-02 3.43E-02 4.90E-02 7.50E-02 7.82E-02
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TM0_1 TM0_2 TM0_3 TM0_4 TM0_5 TM0_6 TM1_1 TM1_2 TM1_3 TM1_4 TM1_5 TM1_6 TM2_1 TM2_2 TM2_3
folE 0.36526 0.78575 0.18864 0.57972 8.33435 12.44627 0.07828 0.03171 10.22857 3.44574 N/A N/A 16.6308 4.89199 0.67712
nudB 0.59139 0.48655 0.79922 0.25515 2.76082 7.62449 25.7612 1.96097 0.37315 0.07304 N/A N/A 27.04895 0.10799 12.79038
folB 0.67976 1.46232 1.00293 3.08208 0.64068 0.95678 0.39662 0.16069 8.806 2.96651 26.76261 7.0286 1.92057 0.56494 294.12125
folK 1.32881 1.09325 0.6752 0.21556 1.40806 3.88862 2.10922 0.16056 0.26505 0.05188 N/A N/A 2345.2761 9.36294 3.03182
folP 0.39862 0.85753 0.53284 1.63745 0.51983 0.7763 1.03646 0.4199 2.21088 0.74479 35.60461 9.35075 1.11291 0.32736 35.53351
aroF 1.81661 1.49458 2.37167 0.75716 5.61169 15.49767 0.81689 0.06218 12.5303 2.4528 N/A N/A 22.95957 0.09166 3.11704
aroH 0.46404 0.99826 0.53905 1.65655 0.26344 0.39342 2.06612 0.83706 1.58474 0.53386 38.77918 10.18448 2.86112 0.84161 5.00824
aroG 0.16213 0.13339 7.41593 2.36755 1.21426 3.35339 3.15176 0.23992 4.91502 0.96211 0.00059 0.00059 0.35215 0.00141 1.61172
aroB 0.17732 0.38147 1.35156 4.15345 0.71999 1.07521 1.01708 0.41206 1.22168 0.41155 179.56178 47.15788 2.67598 0.78715 142.88444
aroD 1.64903 1.3567 652.27863 208.24152 0.10937 0.30205 0.41973 0.03195 729.1358 142.72822 N/A N/A 6.57478 0.02625 6.25491
aroE 0.66474 1.43 0.51443 1.58087 1.42212 2.12375 0.21466 0.08697 10.15 3.41927 12.81845 3.36648 0.25152 0.07399 12.68532
ydiB 0.59528 0.48975 2.06643 0.65971 0.11116 0.307 0.70086 0.05335 1.38586 0.27128 168.8177 168.8177 218.21572 0.87117 0.10925
aroK(aroL) 0.1472 0.31666 0.23735 0.72939 1.62355 2.42456 0.16354 0.06626 2.73661 0.92189 N/A N/A 4.28697 1.26102 2.06241
aroA 0.54688 0.44993 0.37094 0.11842 2.17291 6.00089 0.60608 0.04614 3.20495 0.62737 34.93191 34.93191 6.54396 0.02613 10.97559
aroC 0.7041 1.51467 0.84144 2.58581 0.29526 0.44094 0.29901 0.12114 0.46185 0.15558 8.70937 2.28732 0.9574 0.28162 0.57282
pabBpabA 7.62834 6.27603 0.31803 0.10153 0.04838 0.1336 4.43167 0.33734 1946.9088 381.1071 N/A N/A 119.44814 0.47687 0.03827
pabC 0.61429 1.32147 0.33335 1.0244 1.01058 1.50918 1.72865 0.70034 4.22898 1.42463 97.34178 25.56464 3.03626 0.89312 34.56321
folC 1.36309 1.12145 2.03681 0.65026 0.37478 1.03501 0.88799 0.06759 23.18419 4.5383 N/A N/A 1137.6157 4.54165 3.04928
folA(folM) 0.24651 0.53029 0.16351 0.50247 0.71221 1.0636 0.31014 0.12565 58.50645 19.70929 4.14723 1.08918 5.00979 1.47364 1.25231
glyA 0.9131 0.75123 0.77609 0.24777 0.6838 1.88845 1.32403 0.10079 0.30287 0.05929 13.37666 13.37666 24.91178 0.09945 13.53528
gcvH 3.17323 6.82632 0.53349 1.63946 0.79614 1.18892 0.19002 0.07698 0.14633 0.0493 0.44373 0.11654 0.00364 0.00107 1.03528
gcvP 8.83041 7.26501 1.76408 0.56319 1.21912 3.36682 2.90056 0.22079 0.0346 0.00677 4.05252 4.05252 0.0724 0.00029 0.61464
gcvT 3.07319 6.61112 0.29328 0.90127 0.54496 0.81382 0.0147 0.00595 0.37775 0.12725 N/A N/A 0.21338 0.06277 0.00017
lpdA 1.24557 1.02476 0.90305 0.2883 7.99139 22.06963 1.62462 0.12367 20.24045 3.96207 0.07944 0.07944 13.23221 0.05283 11.93001
folD 0.44959 0.96716 1.34489 4.13295 1.49373 2.23068 0.77458 0.31381 1.94945 0.65672 24.65737 6.4757 2.59685 0.76387 53.27228
ygfA(fau) 3.24905 2.67308 0.06971 0.02226 306.66576 846.91179 0.2401 0.01828 169043.53 33090.246 N/A N/A 12.39328 0.04948 445.6963
metF 0.50174 1.07936 1.26067 3.87412 0.59521 0.88886 2.54641 1.03164 1.74772 0.58876 8.03094 2.10915 3.14149 0.92408 26.98028
metH 2.09631 1.72469 3.01165 0.96148 1.07655 2.97307 11.03219 0.83978 N/A N/A 37147.332 37147.332 4.68673 0.01871 2.92835
codB 0.78602 1.6909 1.76015 5.40906 0.46143 0.68908 1.41337 0.57261 9.23092 3.10965 4.95275 1.30073 6.00246 1.76564 0.19666
putP 5.82989 4.7964 1.12191 0.35817 N/A N/A 1.7512 0.1333 0.10828 0.02119 438.22448 438.22448 0.46988 0.00188 1.44841
gadC 0.73873 1.58916 1.69004 5.19361 0.80303 1.19922 0.9765 0.39562 1.48575 0.50051 2.51654 0.66091 0.00144 0.00042 0.05443
dsdX 3.63345 2.98933 1.67 0.53315 0.24091 0.66531 8.0756 0.61472 0.72059 0.14106 N/A N/A 2.01798 0.00806 2.49776
adeQ 0.60233 1.29574 1.7467 5.36774 0.47046 0.70257 1.25254 0.50745 133.92173 45.11473 468.55468 123.05538 10.85048 3.19169 N/A
pnuC 0.53061 0.43654 0.58055 0.18534 0.19134 0.52842 1.57818 0.12013 2.30457 0.45112 1.1135 0.99733 32.74395 0.13072 400.74948
nupC 1.17304 2.52347 0.75414 2.31753 0.40859 0.61017 1.5603 0.63213 1.74759 0.58872 57.46549 15.09202 2.96244 0.87141 6.80025
nupG 1.3766 1.13256 1.81846 0.58055 0.15568 0.42995 0.70904 0.05397 0.06524 0.01277 N/A N/A 17.36109 0.06931 184.65869
panF 0.46485 N/A 0.32541 N/A 0.66963 N/A 2.46831 N/A 2.96847 N/A 3.80767 N/A 3.3996 N/A 45.14203
aroP 1.716 1.4118 0.96005 0.3065 1.09265 3.01755 9.32967 0.71019 0.25152 0.04924 739.93365 739.93365 0.8439 0.00337 3.32443
glcA 0.7114 1.53038 0.25327 0.77832 0.63703 0.95133 7.26403 2.94291 1.6429 0.55345 2.74593 0.72116 1.6993 0.49985 4.38479
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uhpT 1.71313 1.40944 12.50629 3.99266 1.29978 3.58957 7.23705 0.55089 0.62771 0.12287 7.29889 7.29889 28.80599 0.115 0.23953
cycA 1.57642 3.39123 0.17718 0.5445 0.74746 1.11623 1.19225 0.48302 22.44629 7.56157 42.02519 11.03698 0.25736 0.0757 7.78721
citT 2.47865 2.03925 18.67048 5.9606 1.38135 3.81485 187.29752 14.2573 0.2991 0.05855 2.62905 2.62905 5.81502 0.02322 2.07053
shiA 0.9985 2.14799 0.48208 1.48147 0.93963 1.40321 0.77064 0.31221 1.09822 0.36996 16.76865 4.40391 0.15579 0.04583 0.73925
cysG N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
hcaT N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
idnT N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
accA 0.33784 0.72677 0.3158 0.97048 2.21474 3.30743 1.04117 0.42182 2.03649 0.68604 141.20046 37.08313 1.95747 0.57579 26.49026
accB 0.57399 0.47224 0.60331 0.19261 0.64158 1.77183 5.75893 0.43838 0.12313 0.0241 90.56545 90.56545 37.64669 0.1503 8.73355
accC 0.17431 0.37498 0.33162 1.01909 0.68849 1.02818 1.59147 0.64476 0.86882 0.29268 5.29279 1.39003 0.99824 0.29363 11.07038
accD 0.22106 0.18187 0.6662 0.21269 1.10274 3.0454 2.67098 0.20332 0.12614 0.02469 3.44771 3.44771 24.41141 0.09746 0.94544
fabA 0.2291 0.49284 0.2142 0.65824 1.87667 2.80256 0.32394 0.13124 3.2923 1.10909 1.51517 0.39792 21.3928 6.29274 125.83787
fabB 0.22765 0.18729 13.06729 4.17176 6.74035 18.61467 20.75703 1.58005 0.10648 0.02084 0.86473 0.86473 186.96306 0.7464 26.34014
fabD 0.96763 2.08158 0.39096 1.20146 4.07336 6.08303 0.09018 0.03653 4.22548 1.42345 0.00824 0.00216 12.50615 3.67871 16.94406
fabF 0.33679 0.27709 2.88077 0.91969 11.23155 31.0179 2.78302 0.21185 0.2168 0.04244 3.78148 3.78148 19.18531 0.07659 64.71332
fabG 0.62056 1.33497 0.20232 0.62175 2.47491 3.69596 0.15682 0.06353 3550.3133 1196.0078 9.02642 2.37059 2.92978 0.8618 5.01389
fabH 0.39028 0.32109 0.39609 0.12645 5.61576 15.50893 2.00529 0.15264 0.21672 0.04242 0.03057 0.03057 119.9484 0.47886 75.30697
fabI 0.27854 0.5992 0.44703 1.37375 1.32071 1.97231 0.5463 0.22132 0.91683 0.30886 0.24832 0.06521 N/A N/A 7.66479
fabZ 0.44569 0.36668 46.24944 14.76524 872.31669 2409.0569 0.00125 0.0001 29037.841 5684.153 N/A N/A 4.18941 0.01673 N/A
cydX 1.66028 3.57163 11.1427 34.24234 3.64911 5.44948 0.07858 0.03184 0.4941 0.16645 7.67901 2.01672 0.34754 0.10223 1.98782
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TM2_4 TM2_5 TM2_6 TM3_1 TM3_2 TM3_3 TM3_4 TM3_5 TM3_6 pvals_0H pvals_1H pvals_2H pvals_3H
0.015 N/A N/A 9311.6605 39.81951 48.49194 1.84281 10000.973 134.85068 2.53E-02 3.83E-02 3.22E-02 1.69E-02
12.79038 5.38E+009 5.38E+009 2.0267 20.6105 1.77865 1.77865 72.15259 72.15259 3.95E-02 4.05E-02 1.75E-02 1.10E-02
6.51546 0.45093 0.64525 N/A N/A 33.48532 1.27252 6115.41 82.4587 4.55E-02 1.62E-02 3.54E-02 3.81E-02
3.03182 21.59205 21.59205 6.02083 61.22888 5.2993 5.2993 0.096 0.096 4.44E-02 5.23E-02 3.51E-02 2.71E-02
0.78715 0.77029 1.10224 22.45896 0.09604 6.52902 0.24812 180.32008 2.43139 2.99E-02 2.57E-02 3.77E-02 2.92E-02
3.11704 N/A N/A 0.7828 7.96068 0.09789 0.09789 1.84817 1.84817 1.77E-02 3.82E-02 3.16E-02 4.04E-02
0.11094 65098.438 93151.927 N/A N/A 0.07249 0.00275 446.39765 6.01912 2.45E-02 2.49E-02 1.83E-02 3.87E-02
1.61172 203.04013 203.04013 0.1163 1.18276 0.09249 0.09249 0.11338 0.11338 2.54E-02 5.41E-02 1.75E-02 1.05E-03
3.16522 5.43805 7.78152 N/A N/A 8.88107 0.3375 352.99336 4.75968 6.25E-02 2.58E-02 3.11E-02 3.74E-02
6.25491 0.02733 0.02733 0.62161 6.32142 0.0694 0.0694 0.21807 0.21807 2.40E-02 3.00E-02 1.82E-02 8.13E-02
0.28101 12260785 17544441 N/A N/A 0.28055 0.01066 6017.7052 81.14127 2.92E-02 1.22E-02 1.83E-02 3.84E-02
0.10925 16.15118 16.15118 0.24615 2.50318 0.00109 0.00109 0.18759 0.18759 3.47E-02 1.77E-02 3.00E-02 2.83E-02
0.04569 3.52312 5.04138 N/A N/A 241.73434 9.1865 1299958.5 17528.323 8.26E-02 9.67E-02 8.04E-03 3.84E-02
10.97559 0.21005 0.21005 1.2375 12.58479 0.07035 0.07035 4650.6131 4650.6131 5.40E-02 1.72E-02 1.42E-02 1.74E-02
0.01269 23.33771 33.39486 14.76492 0.06314 2.98893 0.11359 0.20687 0.00279 8.63E-02 4.99E-02 2.06E-02 4.37E-02
0.03827 N/A N/A 1.96973 20.03115 2.38815 2.38815 0.00042 0.00042 3.72E-02 2.98E-02 4.02E-02 3.21E-02
0.76565 1795.6965 2569.5331 193.54019 0.82764 2.55111 0.09695 3.82354 0.05156 8.68E-02 2.39E-02 1.79E-02 3.57E-02
3.04928 N/A N/A 3.34368 34.00355 0.03319 0.03319 0.00004 0.00004 6.99E-02 3.38E-02 3.87E-02 3.91E-02
0.02774 7.14222 10.22009 388.31737 1.66056 250.05905 9.50286 0.58509 0.00789 1.77E-03 2.26E-02 1.07E-02 1.81E-02
13.53528 N/A N/A 9.01565 91.68471 3.44765 3.44765 3.69751 3.69751 6.03E-02 2.28E-02 9.86E-03 2.67E-02
0.02293 35.99515 51.50688 N/A N/A 0.56045 0.0213 2.94497 0.03971 2.20E-02 3.09E-06 2.02E-02 8.86E-02
0.61464 N/A N/A 0.02344 0.23836 0.15833 0.15833 1.04954 1.04954 9.87E-03 3.33E-02 2.76E-03 3.49E-03
0 570.52185 816.38226 N/A N/A 0.42645 0.01621 0.39882 0.00538 3.47E-02 2.11E-04 1.84E-02 6.54E-04
11.93001 0.00006 0.00006 1.01924 10.36515 0.05995 0.05995 754.97389 754.97389 2.47E-02 3.48E-02 1.20E-02 1.72E-02
1.1801 5.98563 8.56507 40.12801 0.1716 23.68333 0.90002 954.83874 12.87481 2.06E-02 2.71E-02 2.42E-02 3.25E-02
445.6963 51.63562 51.63562 35.59419 361.97518 36.95097 36.95097 0.14117 0.14117 2.28E-02 2.98E-02 1.17E-02 2.32E-02
0.59768 3.46795 4.96243 32.31552 0.13819 10.31285 0.39191 658.515 8.87926 5.08E-02 1.91E-02 2.26E-02 3.27E-02
2.92835 0.06586 0.06586 0.3133 3.18615 0.13073 0.13073 0.38116 0.38116 4.42E-03 1.82E-02 3.83E-02 6.36E-02
0.00436 0.00004 0.00006 146.91432 0.62825 1.20698 0.04587 0.0262 0.00035 3.38E-02 1.27E-02 7.50E-02 3.74E-02
1.44841 0.164 0.164 0.07486 0.76127 0.1636 0.1636 3.99426 3.99426 2.29E-02 1.76E-02 2.15E-02 5.34E-02
0.00121 0.00054 0.00078 0.00269 0.00001 0.13482 0.00512 0.20004 0.0027 2.60E-02 7.96E-02 1.13E-10 1.47E-07
2.49776 480.85436 480.85436 0.0885 0.90005 0.33436 0.33436 0.06235 0.06235 3.29E-02 5.18E-02 1.73E-02 3.09E-04
N/A 0 0 1552.1081 6.63729 177.39771 6.74155 4327.0052 58.34428 4.01E-02 1.36E-02 3.99E-02 2.07E-02
400.74948 0.15093 0.15093 1.19135 12.11545 0.44053 0.44053 434.05828 434.05828 4.44E-05 7.80E-02 1.57E-02 1.69E-02
0.15064 103.60105 148.24684 279.10585 1.19354 2.19677 0.08348 0.02257 0.0003 4.58E-02 2.55E-02 1.69E-02 3.66E-02
184.65869 N/A N/A 0.57242 5.82121 36.42228 36.42228 21.39168 21.39168 7.57E-02 1.78E-03 1.57E-02 2.50E-03
N/A 0.69884 N/A 233.84671 N/A 26.31408 N/A 74.16331 N/A 3.59E-03 3.35E-03 3.96E-02 2.20E-02
3.32443 0.00105 0.00105 0.81385 8.27649 1.21214 1.21214 4.14463 4.14463 3.15E-02 1.72E-02 7.24E-02 1.06E-02
0.09713 0.28839 0.41267 104.97557 0.44891 9.77097 0.37132 14.35058 0.1935 3.21E-02 1.64E-02 7.46E-02 2.74E-02
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0.23953 0.82262 0.82262 0.37248 3.78792 11.15552 11.15552 12.71306 12.71306 1.38E-02 1.21E-02 4.18E-02 1.60E-03
0.1725 0.61577 0.88112 67.03153 0.28665 34.39556 1.30712 384.05076 5.17845 6.05E-02 9.81E-03 6.31E-02 2.44E-02
2.07053 0.06515 0.06515 0.20227 2.05699 4.3761 4.3761 0.23905 0.23905 1.37E-02 3.24E-02 4.90E-02 3.21E-02
0.01638 0.02716 0.03887 47.93253 0.20497 1.58697 0.06031 N/A 0.01348 3.47E-02 3.14E-02 8.18E-05 3.99E-02
N/A N/A N/A N/A N/A N/A N/A N/A N/A 5.52E-02 2.56E-02 2.91E-02 3.54E-02
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
0.58682 2.36863 3.38936 938.26843 4.01232 16.24866 0.61749 0.12047 0.00162 N/A N/A N/A N/A
8.73355 224.69149 224.69149 4.87964 49.62354 16.53597 16.53597 21.08012 21.08012 2.48E-02 1.68E-02 1.22E-02 1.97E-03
0.24523 2.65656 3.80137 674.75935 2.88548 20.95324 0.79627 2.88271 0.03887 4.51E-03 4.05E-02 2.51E-02 3.46E-02
0.94544 N/A N/A 2.56381 26.07266 0.92865 0.92865 1.06228 1.06228 8.42E-02 3.91E-02 4.15E-02 3.32E-02
2.7876 138.64925 198.39869 14564.777 62.28344 10.34182 0.39301 0.01416 0.00019 9.20E-02 8.01E-02 6.16E-03 3.61E-02
26.34014 2.50498 2.50498 4.30491 43.77875 1.1081 1.1081 1.20772 1.20772 9.58E-03 4.07E-02 2.36E-02 3.18E-02
0.37535 73837325 105656746 6269.1386 26.80875 2.23371 0.08489 4843703.8 65311.323 1.62E-02 9.61E-02 1.83E-02 3.56E-02
64.71332 N/A N/A 2.67789 27.23283 0.69152 0.69152 0.85405 0.85405 2.29E-02 3.34E-02 1.14E-02 3.49E-02
0.11107 1.71977 2.46089 1352.9869 5.78579 0.7739 0.02941 24648.098 332.34895 4.11E-02 2.34E-02 1.54E-02 3.29E-02
75.30697 435.45013 435.45013 7.23571 73.58356 0.56221 0.56221 0.00321 0.00321 3.27E-02 1.26E-02 6.21E-03 3.41E-02
0.16979 24007.098 34352.705 265.03585 1.13337 0.81254 0.03088 0.04082 0.00055 9.96E-02 4.26E-04 1.91E-02 3.69E-02
N/A N/A N/A 4.41348 44.88289 360231.24 360231.24 0.0053 0.0053 2.19E-02 2.98E-02 6.90E-02 1.75E-02
0.04403 0.04133 0.05914 2.22459 0.00951 1.33319 0.05066 0.02128 0.00029 1.36E-02 5.70E-02 1.30E-02 3.57E-02
